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 ABSTRACT 
ROLE OF RIGIDITY AND FLEXIBILITY OF FUNCTIONAL GROUPS WITHIN THE 
INTERIOR OF SUPRAMOLECULAR ASSEMBLIES AND THEIR IMPLICATIONS 
 
 
FEBRUARY 2018 
 
OYUNTUYA MUNKHBAT, 
 
B.S., BOGAZICI UNIVERSITY 
 
M.S., BOGAZICI UNIVERSITY 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Sankaran Thayumanavan  
 
 
 
Engineering of supramolecular assemblies at molecular level renders 
functional nanomaterials that present explicit response to certain environmental 
changes. Systematic structure-property correlation studies will unravel the 
fundamental design constraints of these functional nanomaterials that fulfill the 
emergent need. This dissertation will primarily focus on understanding the role of 
rigidity and flexibility of functional groups within amphiphilic assemblies and 
employing this basic concept in drug delivery and diagnostics applications.  
Supramolecular assemblies formed by amphiphilic dendrimers and polymers 
are preferred for this study as they exhibit high thermodynamic stability and 
structural flexibility. The role of aromatic interaction on the unimer-aggregate 
dynamic equilibrium was systematically studied using facially amphiphilic 
dendrimers. We show that the aromatic interaction contributes to the stability of 
guest encapsulation by generating more rigid assemblies via pi-pi stacking. 
viii 
Fundamental principles obtained from these rigid assemblies were translated into 
synthetically more feasible polymeric designs and exploited to develop stable 
nanocarriers with enhanced encapsulation efficiency for drug delivery applications. 
On contrary to interior rigidity, an effect of the interior flexibility or mobility 
of embedded hydrophobic functional groups were explored. We developed a new 
strategy to generate interior flexibility in polymeric nanogels by using cleavable 
functional groups and demonstrated the enhancement in segmental mobility of 
fluorine probes localized inside of the nanoassembly. We showed the feasibility of 
this responsive polymeric system in 19F MRI applications. 
These results show that subtle molecular lever alterations can be utilized to 
control the behavior of nanoscale materials and tune the properties for intended 
applications.  
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CHAPTER 1 
                                                         INTRODUCTION 
Engineering of functional materials at the atomic and molecular level is 
termed as nanotechnology. Nanoscale materials that carry a unique property of large 
surface area per volume have been a center of research for the last few decades and 
have been applied to advance the field of medicine, diagnostics, electronics, food and 
energy. Molecular self-assembly, which is predominantly governed by noncovalent 
interactions, is one of the most explored and abundantly utilized approach to 
fabricate nanomaterials of desired size and shape. 
1.1 Supramolecular Self-Assembly 
Self-assembly of an amphiphilic molecule occurs when there is an appropriate 
hydrophilic-lipophilic balance (HLB) in the constituent functionalities within the 
molecule. When an amphiphile is dispersed in aqueous media, the molecules organize 
themselves to optimize the non-covalent interactions such as hydrogen bonding, van 
der Waals forces, electrostatic interactions, and hydrophobic interactions.1–5 In 
aqueous media, where hydrophobic forces play a dominant role, the hydrophobic 
functional groups of these molecules are typically buried in the assembly to minimize 
exposure to water.6,7 Depending on the nature of inherent properties, for instance the 
molecular volume and shape of the functional groups, different classes of self-
assembled aggregates such as micelles, inverse-micelles, liposomes, and vesicles etc. 
are formed. The interiors of these assemblies have often exploited for sequestering 
hydrophobic and/or hydrophilic guest molecules, which have implications in a 
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variety of areas such as drug delivery, sensing and diagnostics (Figure 1.1). For 
example, micellar structures are capable of solubilizing water insoluble lipophilic 
drug molecules in aqueous environment by housing them in their hydrophobic core, 
whereas vesicles are capable of encapsulating both hydrophobic and hydrophilic 
guest molecules in their hydrophobic membranes and water cavity respectively. 
 
Micelles are supramolecular structures that are formed from self-assembly of 
amphiphilic molecules in aqueous environment, in which hydrophilic groups are in 
contact with water and the hydrophobic groups are buried inside the core to 
minimize the exposure to water. Since the process is mainly driven by hydrophobic 
interaction, micelles form only above certain concentration, which is referred as 
critical aggregation concentration (CAC). Surfactants, small molecule amphiphilic 
agents, are widely utilized in industry as detergents, emulsifiers, and dispersants. 
 
Figure 1.1: Representation of amphiphilic assemblies as nanocarriers. 
Inverse-micelle
• Biomarker 
extraction
Vesicle:
• Hydrophobic & 
hydrophilic 
delivery
Micelles:
• Hydrophobics
delivery
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However, comprehensive applications of these agents are impeded by the inherently 
low mechanical stability associated with their high CAC values. In this regard, self-
assemblies of amphiphilic macromolecules such as dendrimers and polymers 
attracted a considerable attention as they exhibit relatively low CAC and high 
thermodynamic stability. 8–10 
Amphiphilic assemblies exist in dynamic equilibrium with their unimers as the 
structure is constructed by weak noncovalent interactions. By engineering the 
balance between stabilizing and destabilizing interactions within molecular 
structure, dynamic equilibrium of amphiphilic assemblies can be tuned for intended 
application.5 This dissertation will primarily focus on supramolecular assemblies 
formed by amphiphilic dendrimers and polymers.  
1.2 Stimuli-Responsive Supramolecular Assemblies 
Supramolecular self-assemblies that respond to applied stimuli are actively 
being developed and exploited in variety of fields including controlled drug 
delivery,11–13 diagnostics,14–16 tissue engineering,17,18 catalysis19,20 and coatings.21,22 
Advances in material science enabled the development of wide range of stimuli-
responsive materials with distinct size, shape and surface properties. Incorporation 
of functional monomers or cleavable likers into the molecular architecture can bring 
stimuli-responsive feature to the resultant self-assembled structure. 
Responsive materials are particularly interesting in perspective of drug 
delivery as achieving on-demand drug release at the disease site is one of the current 
goals of nanomedicine. Despite the tremendous progress in passive (diffusion based 
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delivery via EPR effect) and active (ligand based delivery) targeting in drug delivery 
field, clinical translation of nanoparticle based drugs are still hampered by the lack of 
system that fulfills the requirement of successful delivery platform. 
Stimuli-responsive materials are diverse and can be broadly classified into 
exogenous (external stimulus) and endogenous (internal stimulus) based on the 
source of stimulus.23 The assemblies that respond to external stimuli such as change 
in temperature, exposure to light, magnetic and /or electric field and ultrasound 
waves are referred to as exogenous stimuli-responsive systems. The assemblies that 
respond to cellular microenvironments such as change in pH and redox condition, 
presence of specific sugars, enzymatic and non-enzymatic proteins are regarded as 
endogenous stimuli-responsive systems.  
1.3 Supramolecular Assemblies Based on Dendrimers 
Among diverse supramolecular structures, dendrimers are characterized by 
their unique properties of monodisperse nature, globular shape and well-defined 
surface chemistry. In addition to the privileged multivalency that allows surface 
decoration with therapeutic agents, diagnostic probes and targeting ligands, interior 
pockets of dendrimers can be used as a container for hydrophobic guest molecules, 
which makes them an attractive platform for wide range of applications such as 
nanotherapeutics and diagnostics.8,24–27 
Amphiphilic dendrimers, in which the interior dendritic backbone is 
constructed from hydrophobic moieties and peripheries are decorated with 
hydrophilic functionalities, have been discovered and found to form unimolecular 
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micelles without any self-aggregation.28–30 On the contrary, our group has developed 
a unique class of facially amphiphilic dendrimers which form micelle-like structures 
through amphiphilic self-assembly.31,32 
1.3.1 Facially Amphiphilic Dendrimers 
Amphiphilic dendrimers that display hydrophobic and hydrophilic 
components in each repeat unit of dendritic structure whilst presenting phase 
separation across a rigid longitudinal axis are called facially amphiphilic dendrimers. 
Iterative synthesis of biaryl based AB2 monomer and AB2 core using a convergent 
approach allowed for the preparation of different generations of facially amphiphilic 
dendrimers.33 These dendrimers self-assemble into micelle-like aggregates at low 
concentration and have CAC’s in sub-micromolar range. Unlike the conventional 
unimolecular micelle, facially amphiphilic dendrimers self-aggregate and form 
thermodynamic self-assemblies in the size of 100-200 nm with low polydispersity. 
 
Figure 1.2: Schematic representation of facially amphiphilic dendron with AB2 
core and the formation of micelle from these dendrons. 
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Considering their precise molecular characterization similar to small 
molecules and the ability to show assembly properties like macromolecules, these 
dendrimers provide excellent opportunity to convey structure property relationship 
studies to elucidate the fundamental design criteria for functional supramolecular 
assemblies. Dynamic equilibrium of unimer and aggregate is dictated by the 
stabilizing and destabilizing interactions between hydrophilic and lipophilic 
components. Therefore, subtle change at molecular level can lead to completely 
different macroscopic behaviors. By employing variable functionalities, we have 
designed a series of facially amphiphilic dendrimers with stimuli-responsive 
properties and demonstrated their assembly and disassembly properties (Figure 
1.3). 
 
Figure 1.3: Schematic representation showing disassembly of stimuli-responsive 
facially amphiphilic dendron assemblies through unimer-aggregate equilibrium. 
LCST of hydrophilic unit 
causes change in HLB
Charge generation causes 
change in HLB
Protein-ligand binding 
induces change in HLB
Enzyme/light cleavage 
causes change in HLB
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1.3.2 Stimuli-Responsive Facially Amphiphilic Dendrimers 
Temperature and light responsive systems are the prominent examples of 
exogenous response. In particular, temperature is one of the most explored stimulus 
as a remote control for nanoassemblies in drug delivery. Slight changes in 
temperature alters the physical properties of the nanocarrier and triggers the release 
of cargo through changes in conformation and solubility. These temperature-
responsive materials are generated by the incorporation of thermo-sensitive 
functional groups into the amphiphilic design such as Poly(N-isopropylacrylamide) 
(PNIPAAM) and polyethylene glycol (PEG) as two of the popular examples.34–36 These 
polymers reversibly phase separate at elevated temperature, which is driven by the 
destabilized H-bonding with surrounding water molecules and exhibit visible 
turbidity at their cloud point, which is also known as lower critical solution 
temperature (LCST). 
We designed and developed temperature-sensitive micellar assemblies based 
on facially amphiphilic dendrimer. Installation of PEG groups in each layer of repeat 
 
Figure 1.4: (a) Structure of temp sensitive dendron with the illustration of 
PEG-hydration through H-bonding. (b) LCST behavior of G1 dendron at 42 oC. 
G2 Dendron
a) b)
H-bonding is
destabilized
Precipitation
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unit generated dendritic micelles that show generation dependent LCST, having 42 
°C, 32 °C, and 31 °C for G1, G2, and G3 respectively (Figure 1.4).32 Further studies 
based on amphiphilic oligomers revealed that the covalent attachment of PEG groups 
add cooperativity to the temperature-responsiveness of these type of 
nanoassemblies.37 Recently, we have discovered an unusual size-transition below 
LCST for G1 dendrons, which is driven by extensive hydration of PEG groups at low 
temperature.38 
Light-sensitive materials are advantageous as they can provide non-invasive 
and site-specific therapeutic delivery. Depending on the chemical transformation 
upon light exposure, light-responsive materials can be categorized as reversible and 
irreversible. Reversible light responsive systems make use of light induced 
isomerization reactions such as cis-trans isomerization of azobenzene derivatives, 
while irreversible systems employ photo-labile linkers. 
 
 
Figure 1.5: Schematic representation of anticipated disassembly mechanism 
when light or enzyme is applied as stimulus. In both cases, triggered 
disassembly and guest release are obtained through a loss of HLB. 
Hydrophobic unit is 
converted to 
hydrophilic
a)
b)
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We have demonstrated the light triggered disassembly of amphiphilic 
dendrimer micelle by using photo-cleavable linker (Figure 1.5). Incorporation of o-
nitrobenzyl ester functionality, which is a well-known photo-labile linker, facilitated 
the disturbance of HLB in amphiphilic assembly upon exposure to UV light. Briefly 
explained, the photo-cleavage of hydrophobic functional groups resulted in 
conversion of amphiphilic dendron to hydrophilic structure and destabilized the 
assembly, leading to disassembly and subsequent guest release.39 
Similar concept was exploited for the design of endogenous response. Enzyme 
responsive dendrimer was made by using enzyme-cleavable linker in place of light-
responsive linker. We observed enzyme-induced changes in HLB and their 
disassembly, similar to that of light-responsive dendrimer, even though the 
hydrophobic substrate was not accessible to large size enzyme.40 This work has 
elucidated an important fundamental understanding about the mechanism of 
disassembly, in which the dynamic equilibrium between unimer and aggregate play 
a role in exposing the hydrophobic substrate to enzyme thereby facilitating the 
substrate cleavage (Figure 1.5b). 
Finally, we have developed non-enzymatic protein-responsive dendrimers 
and demonstrated binding induced disassembly of micelle-like assemblies through 
protein-ligand interaction. Biotin ligand was placed on the hydrophilic portion of the 
dendrimer and exposed to the surface of micelle to facilitate access to a large protein 
called extravidin (complementary to biotin). We envisaged that when small molecule 
ligand binds to large hydrophilic protein, HLB of the overall system will be 
significantly affected causing disassembly (Figure 1.6). This specific protein binding 
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induced disassembly, against other noncomplementary proteins as control, was 
confirmed by a change in assembly size and the release of guest molecules.41 Recently, 
we have explored rather challenging aspect of binding induced disassembly, where 
the ligand is buried inside of the hydrophobic pocket. Although the ligand was not 
exposed on the surface of hydrophilic corona, disassembly of aggregate was again 
confirmed by the guest release profile as well as the size decrease. We believe, this 
process was enabled by the equilibrium between unimer and aggregate similar to 
what we observed in enzyme-responsive dendrimers.42 
1.4 Supramolecular Assemblies Based on Polymers 
Nanoscale materials based on synthetic or natural polymers have been 
increasingly applied in biomedical research, particularly in cancer nanotherapeutics 
and cancer diagnostics.43–46 Diverse polymeric nanostructured materials such as 
micelles, polymersomes, nanogels, nanocapsules, nanofibers and nanocomposites 
etc. have been discovered and explored. These polymer-based supramolecular 
 
 
Figure 1.6: Schematic representation of binding induced disassembly 
mechanism when protein is applied as stimulus. HLB is disturbed when protein 
and ligand bind irreversibly and cause disassembly. 
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assemblies are particularly advantageous because of their tailorable structure that 
offer control over size, shape, mechanical property and surface chemistry, all of which 
are important parameters for biomedical applications.  
Polymeric micelles and crosslinked polymer nanogels are actively being 
investigated for the delivery of anticancer agents, therapeutic proteins, reporter 
molecules and so on. These delivery platforms exhibit much higher stability 
compared to conventional liposomal formulation of therapeutic agents owing to their 
low CAC values. In particular, nanogel systems show exquisite intactness and stability 
upon dilution since these are crosslinked particles.47–49 
Challenges in clinical translation of polymer based nanomedicine today is the 
in vivo encapsulation stability of therapeutic agent.50,51 There have been number of 
successful candidates in clinical trials in recent years. However, many of them were 
no able to reach the approval stage because of the lack of efficacy.52,53 Therefore, 
tremendous efforts are being devoted to achieving on-demand drug release using 
stimuli-responsive systems that stably encapsulate the cargo and release it at the 
target site in response to specific stimuli of the tumor microenvironment. 
1.4.1 Stimuli-Responsive Polymer Micelles 
Polymeric micelles are formed by the self-assembly of amphiphilic block 
copolymer or random copolymer. These sub-microscopic assemblies present core-
shell type structures with inner core as a hydrophobic pocket and outer shell as a 
hydrophilic corona. Stimuli-responsive polymeric micelles can be fabricated by 
installing functional monomers or responsive linkers into the polymer structure. 
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Our group has designed a multi stimuli-responsive block copolymer (BCP) 
micelles that undergo disassembly in response to each stimulus separately as well as 
simultaneously. Amphiphilic block copolymer that consists of acid-sensitive 
hydrophobic group (THP-protected HEMA), temperature-responsive hydrophilic 
(PNIPAM) group and redox-sensitive (dithiol) connectivity was shown to form 
micelle and non-covalently encapsulate hydrophobic guest molecule in aqueous 
media. Disassembly of micellar structure and the subsequent guest release have been 
achieved under each condition, where there is an increase in temperature, a decrease 
in pH and a reducing environment. In all cases, disassembly is triggered by the loss of 
HLB as illustrated in Figure 1.7. Conversion of hydrophilic block to hydrophobic, 
conversion of hydrophobic block to hydrophilic, scission of two blocks-each lead to 
drastic change in solution property and disassembly of nanostructure. The tunable 
release kinetics of this responsive assembly has been demonstrated by the 
application of single or dual-stimuli.54 
 
 
Figure 1.7: Schematic representation of binding induced disassembly 
mechanism when protein is applied as stimulus. HLB is disturbed when protein 
and ligand bind irreversibly and cause disassembly. 
Block copolymer micelle
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1.4.2 Stimuli-Responsive Crosslinked Polymer Nanogels 
Nanogels presented a promising delivery platform in terms of maintaining the 
stability of non-covalently entrapped therapeutic agents within blood circulation. In 
recent years, wide range of chemically or physically crosslinked polymer nanogels 
have been developed to achieve controlled release of anticancer agents exclusively in 
tumor environment.  
Recently, stimuli-responsive crosslinked nanogel system that respond to 
reducing environment has been developed in our group. Random copolymer 
composed of PEG (hydrophilic unit) and pyridyl disulfide (hydrophobic unit) was 
shown to form micelle like aggregate in water. One pot drug encapsulation and 
nanogel formation followed by surface functionalization was demonstrated by using 
disulfide exchange chemistry. This versatile nanogel system exhibited excellent 
control over crosslink density, size tunability and encapsulation stability in addition 
to the triggered release of guest molecule in response to redox milieu.55–57 
 
 
Figure 1.8: (a) Schematic representation of nanogel preparation. (b) Structure 
of polymer precursor, nanogel and functionalized nanogel. 
Polymer 
precursor
Crosslinking reaction 
intermediate Nanogel
Functionalized 
nanogel
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1.5 Conclusion 
In this chapter, we have briefly introduced the basics of self-assembly and 
supramolecular self-assemblies based on amphiphilic dendrimers and polymers. We 
discussed that the careful engineering of these macromolecules at molecular level 
renders functional nanomaterials that show explicit response to certain 
environmental changes. These stimuli-responsive systems hold great promise for 
biological applications due to their stability and structural flexibility. Systematic 
structure-property relationship studies will unravel the fundamental design 
constraints of functional nanomaterials that fulfill the emergent need. 
This dissertation will focus on understanding the role of rigidity and flexibility 
of functional groups within the supramolecular assemblies followed by the potential 
applications in drug delivery and diagnostics. In Chapter 2, effect of aromatic 
interaction on unimer aggregate equilibrium of facially amphiphilic dendron will be 
discussed. Dynamic exchange of host dendrons as well as the stability of 
noncovalently encapsulated guest molecules in self-assembling dendrons with 
varying interior rigidity comprised of aromatic functionality will be explored. In 
Chapter 3, fundamental principles obtained from interior rigidity has been translated 
into synthetically more feasible polymeric designs. Contribution of pi-pi stacking on 
the encapsulation efficiency and the encapsulation stability of anticancer drugs 
within amphiphilic polymer nanogels will be demonstrated.  
On contrary to interior rigidity, in Chapter 4, effect of interior flexibility of 
supramolecular assemblies on the mobility of embedded hydrophobic functional 
groups will be described. Strategy to generate interior flexibility in polymeric 
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nanoassemblies by combining crosslinkable and degradable functional groups will be 
discussed followed by further implementation of this technology in theranostic 
application of 19F MRI-guided drug delivery. 
In Chapter 5, the dissertation will be concluded with the general summary of 
findings followed by future direction, where the strategy to obtain image-guided 
therapeutic release capability of polymer nanogels will be provided with the 
combination of rigid and flexible functionalities. 
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CHAPTER 2 
 ROLE OF AROMATIC INTERACTIONS IN TEMPERATURE-SENSITIVE 
AMPHIPHILIC SUPRAMOLECULAR ASSEMBLIES 
Adapted with permission from Munkhbat, O.; Garzoni, M.; Raghupathi, K. R.; 
Pavan, G. M; Thayumanavan, S. Role of Aromatic Interactions in Temperature-
Sensitive Amphiphilic Supramolecular Assemblies. Langmuir 2016, 32, 2874-2881. 
Copyright © 2016 American Chemical Society. 
2.1 Introduction 
Amphiphilic supramolecular assemblies have been of great interest due to 
their potential utility in a variety of applications such as drug delivery, bio-sensing 
and catalysis.1-10 Understanding the molecular design elements that control not only 
the final macroscopic structural features, but also the dynamic properties of the 
assembly is critical in developing versatile new supramolecular assemblies. In this 
context, there is a notable interest in temperature-sensitive systems, as these 
facilitate convenient extrinsic control over self-assembly.11-17 Oligo- and poly- 
ethylene glycol (OEG and PEG) based systems have attracted considerable attention, 
because of their hydrogen bonding based interactions with water that affords 
temperature-dependent hydrophilicity.18-20 In these cases, aggregation becomes 
stronger at higher temperatures,21,22 because the loss of hydrogen bonding between 
the temperature-sensitive functionalities and water reduces the amphiphile’s 
hydrophilicity.21-23 Thus, most of these sensitivities arise directly from the 
temperature-sensitive moiety itself.  In this work, we show that aromatic interactions, 
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which are tucked within the interiors of the assembly,24,25 can also play a fundamental 
role in controlling the temperature-sensitive behavior of supramolecular assemblies 
(Figure 2.1). 
To evaluate the role of aromatic interactions on the temperature-sensitive 
self-assembly, we designed facially amphiphilic dendrons with variable levels of 
aromaticity (Scheme 2.1). Dendrimers and dendrons are interesting platforms for 
this study, as these combine the advantages of small molecule amphiphiles in that 
they are structurally well-defined and polymers in that they are characterized by high 
thermodynamic stabilities.26-35 The targeted aromatic hydrophobic units include 
phenyl, naphthyl, and anthracyl moieties, having an increasing trend in 
hydrophobicity as well as aromaticity. Cyclohexyl provides a useful comparison with 
 
Figure 2.1: Schematic presentation of temperature dependent size transition 
of amphiphilic assemblies, and role of aromaticity in this phenomenon. 
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a non-aromatic hydrophobic unit with similar geometry and rigidity. To ensure 
uniformity, the dendrons were prepared using a modular approach, where the 
hydrophobic group was ‘clicked’ on to propargyl moieties. 
 
2.2 Molecular Design and Synthesis 
We designed the dendrons such that these molecules can be synthesized using 
a modular approach, providing facile access to the target molecules.  To achieve this, 
we used the G1 dendritic scaffold with propargyl functionalities at every repeat unit 
of the dendron, shown as structure 8 in Scheme 2.2. This functional group was used 
as the handle to simply vary the hydrophobic functional groups using the Hüisgen-
1,3-dipolar cycloaddition reaction, the so-called click chemistry.36-40 Module 8 was 
prepared by reacting the biaryl molecule 6 with the 3,5-dialkoxybenzyl bromide 7 in 
the presence of potassium carbonate and 18-crown-6, as shown in Scheme 2. All the 
targeted dendrons were successfully obtained using the copper-catalyzed click 
reaction between the propargyl core 8 and the azide functionalized alkyl or aryl-
substituted substrates 9-12. The alkyl azides used in the click reaction were obtained 
from the corresponding alkyl bromides by reaction with sodium azide. 
 
Scheme 2.1: Structures of the amphiphilic dendrons and the log P values of 
hydrophobic functional groups. 
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2.3 Temperature-Dependent Aggregation Behavior 
First, we evaluated the self-assembly formation of each of these dendrons in 
water. Since the critical aggregation concentrations of all these dendrons were well 
below 25 M (Figure 2.3), all dendrons were assembled at this concentration. The 
sizes of the assemblies were found to range between 150 and 180 nm at room 
temperature (Figure 2.2a), as discerned by dynamic light scattering (DLS) 
measurements with good correlation functions (>0.85) and dispersities (0.04 and 
0.18) (Figure 2.6 and Table 2.1). We found that the all of the dendrons form spherical 
micelle-like assemblies in water (Figure 2.4). 
 
 
Scheme 2.2: Synthesis of the targeted dendrons (CHE, PHE, NAP and ANT). 
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Figure 2.2: (a) DLS results of the assemblies formed from all dendrons at 25 
oC; (b) Size change for CHE dendron assembly at 25 oC (181 nm) and 5 oC (95 
nm); (c) Temperature dependent DLS measurement for all dendrons from 40 
oC to 5 oC; (d) Temperature dependent transmittance for all dendrons from 70 
oC to 5 oC. 
 
Figure 2.3: CAC of dendrons (a) CHE 13 M, (b) PHE 13 M, (b) NAP 9 M, and 
(d) ANT 10 M. 
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The sizes of these assemblies were then evaluated at different temperatures. 
Interestingly, a significant size reduction from 181 nm at 25 °C to 95 nm at 5 °C was 
observed for the cyclohexyl dendron (CHE) (Figure 2.2b). This is reminiscent of the 
recently reported sub-LCST transition.41,42 The results in Figure 2.2c show that the 
structural transition is most significant at ~18 °C for CHE dendron. The phenyl 
dendron (PHE) also presents a structural transition at ~6 °C.  Interestingly, naphthyl 
(NAP) and anthracyl (ANT) dendrons do not exhibit any sub-LCST transitions, even 
though they also contain PEG groups. These observations provided the first 
indications that the nature of the hydrophobic substituents might have a significant 
influence over the thermal-sensitive behavior of these supramolecular assemblies, 
and that the latter cannot be simply explained by hydrophilic-lipophilic balance 
 
Figure 2.4: TEM image of aggregates formed by dendrons. All the assemblies 
are spherical micelle-like shape. (a) CHE 130 nm, (b) PHE 160 nm, (c) NAP 150 
nm, and (d) ANT 160 nm. 
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(HLB) variations – the behavior of the different aggregates do not have a direct 
correlation with the log P of the substituents (Scheme 2.1). 
Table 2.1: Size and PDI of dendrimers as determined by DLS. 
Temperature CHE  PHE   NAP ANT 
(ºC) 
Size 
(nm) 
PDI Size 
(nm) 
PDI Size 
(nm) 
PDI Size 
(nm) 
PDI 
40 185.1 0.051 181.9 0.086 167.4 0.050 157.7 0.052 
25 180.8 0.051 182.4 0.110 160.6 0.067 149.3 0.072 
20 175.7 0.010 180.4 0.080 164.7 0.009 149.0 0.053 
17.5 157.3 0.081 179.9 0.091 160.3 0.043 148.5 0.059 
15 123.3 0.072 174.7 0.098 159.1 0.070 147.5 0.079 
12.5 98.53 0.182 169.6 0.110 164.2 0.011 148.3 0.037 
10 95.50 0.161 164.4 0.123 160.5 0.043 146.3 0.064 
5 95.69 0.158 86.92 0.117 162.2 0.004 146.3 0.046 
 
 
Figure 2.5: Time dependent size distribution by volume of CHE (a), PHE (b), 
NAP (c), and ANT (d) as determined by DLS.  
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2.4 Temperature-Dependent Exchange of Dendrons 
We tested whether these temperature-sensitive transitions could be related to 
a differential stability of the dendritic assemblies. Thanks to a recently reported time-
lapse fluorescence method, which used a pyrene-labeled dendron (Pyr) as the 
fluorescent probe (Figure 2.7a and b),41 we assessed the residence time of the 
dendrons into the aggregate, and the dynamic exchange of dendrons with the 
solution. Briefly, Pyr exhibits significant excimer emission in the assembled state, as 
the local concentration of the pyrene within the assembly interior is very high. If Pyr 
aggregates are mixed in solution with the other assemblies (CHE, PHE, NAP or ANT), 
a change in the pyrene fluorescence properties indicates that the dendrons can 
 
Figure 2.6: Correlograms of CHE (a), PHE (b), NAP (c) and ANT (d) dendrimers 
as determined by DLS. 
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exchange dynamically between the aggregates in solution (Figure 2.7c). We tracked 
the increase in monomer emission intensity at 379 nm with time-lapse fluorescence 
spectroscopy upon mixing of Pyr dendron with other dendrons (CHE, PHE, NAP and 
ANT), while varying the temperature. Aqueous solutions of the dendrons (25 M) 
were pre-equilibrated at the desired temperature for 30 min and then mixed in a 
cuvette for immediate fluorescence measurement. For all trials, pre-measurement of 
pyrene dendron solution alone was provided for few seconds prior to the addition of 
the mixing dendron to ensure that there was no monomer emission initially. This 
setup allowed us to study whether the monomer exchange dynamics of these 
assemblies vary with the solution temperature. 
 
Figure 2.7: (a) Graphical illustration of dendron exchange experiment between 
Pyr and CHE. (b) Structure of dendron Pyr; (c) Evolution of pyrene monomer 
and pyrene excimer emission of dendron Pyr due to the dendron exchange with 
different concentrations of CHE dendron at 25 oC. 
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First, we compared the CHE and the PHE dendrons.  These are geometrically 
similar, but cyclohexyl units are more hydrophobic than phenyl units (see log P values 
in Scheme 2.1), while they lack aromaticity. The data in Figure 3d and 3e clearly show 
that both dendrons exhibit faster dendron exchange at 5 °C than at 25 °C. Overall, the 
exchange dynamics of CHE is faster than that of PHE. Interestingly, the effect of 
changing the temperature on the assembly dynamics (temperature-sensitivity) is 
also stronger for the CHE than for the PHE dendron.  NAP dendron is expected to be 
more hydrophobic than PHE and similar to CHE based on the log P of the hydrophobic 
moieties (Scheme 2.1). 
 
 
Figure 2.8: (a-d) Time-based fluorescence measurement to monitor dendron 
exchange property of each dendron with fluorescent-labeled dendron Pyr by 
tracking pyrene monomer emission (379 nm) at 5 oC and 25 oC: (d) CHE; (e) 
PHE; (f) NAP; and (g) ANT. 
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Nevertheless, although the hydrophobic moieties of the self-assembling 
dendrons possess comparable hydrophobicity, the dynamics of NAP aggregates was 
found to be less sensitive to temperature changes compared to that of CHE (Figure 
2.8c and a) and similar to that of PHE (see Figure 2.8c and b). These outcomes suggest 
that hydrophobicity itself is not the unique factor in controlling the assembly 
property and that aromatic interactions, which include π-π and van der Waals 
interactions, can play a major role in supramolecular structure and dynamics. 
Remarkably, the most hydrophobic and aromatic dendron ANT was found to be not 
dynamic at any of the temperatures studied, and the most insensitive to temperature 
variations (Figure 2.8d). Conversely, the assembly of non-aromatic CHE is the most 
sensitive one to temperature variations, and the most dynamic one. The dynamic 
behavior of the aggregate seems to become less temperature-sensitive, while the 
aromaticity of the dendrons is increased. 
2.5 Guest Exchange Properties 
Given that the exchange properties of these dendrons vary, it is interesting to 
investigate whether a similar trend, dominated by aromatic interactions, would be 
observed with guest exchange in those assemblies. Note that these amphiphilic 
assemblies can be hosts for non-covalently binding hydrophobic guest molecules in 
the aqueous phase. To test whether the trend exists, we used a recently developed 
fluorescence resonance energy transfer (FRET) based method to acquire guest 
exchange dynamics (Figure 2.9a).43 For this study, we used pyrene and perylene as 
the hydrophobic FRET pair (Figure 2.10). We notice that the CHE dendron exhibited 
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the fastest guest exchange, whereas there was essentially no FRET observed for ANT 
dendron, suggesting that the exchange dynamics in aromatic dendron assemblies are 
in general slower than the non-aromatic CHE dendron (Figure 2.9b). There was a 
systematic trend in guest exchange dynamics of aromatic dendrons from PHE to NAP 
to ANT, which suggests that the stability of the assembly (as determined by the guest 
encapsulation stability) increases with increasing size of the aromatic side chain 
functionality. All these data are consistent with the host exchange properties 
observed previously and highlight the importance of understanding host exchange 
dynamics in amphiphilic supramolecular assemblies. 
 
 
Figure 2.9: (a) Guest exchange experiment using pyrene and perylene; (b) 
Normalized FRET ratio of all dendrons at 25 oC. 
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2.6 Molecular Dynamics (MD) Simulation Study 
Important questions remain open on the origin of the temperature-sensitivity 
in the dendron aggregates. This is probably due to the interactions between the 
hydrophobic moieties inside the aggregates: the real variables in this study. However, 
aromatic and hydrophobic interactions are unavoidably interconnected in the tail-tail 
self-assembly in the real system. We have used all-atom molecular dynamics (MD) 
simulations to obtain molecular-level details of the dendron self-assembly in solution. 
First, we built and pre-equilibrated the single dendrons in water solution. Then, 
according to the same procedure used for similar facially amphiphilic dendrons and 
 
Figure 2.10: FRET of all dendrimer mixtures with excitation of pyrene at 339 
nm: (a-d) CHE, PHE, NAP, and ANT dendron respectively. 
400 450 500 550
0
200
400
600
800
In
te
n
si
ty
Wavelength (nm)
 0sec
 75sec
 150sec
 225sec
 300sec
 375sec
 450sec
 525sec
 600sec
 675sec
 750sec
ex=339nm
400 450 500 550
0
100
200
300
400
500
600
700
In
te
n
si
ty
Wavelength (nm)
 0sec
 75sec
 150sec
 225sec
 300sec
ex=339nm
400 450 500 550
0
200
400
600
800
In
te
n
si
ty
Wavelength (nm)
 0sec
 75sec
ex=339nm
400 450 500 550
0
50
100
150
200
250
300
In
te
n
si
ty
Wavelength (nm)
 0sec
 75sec
 150sec
 225sec
ex=339nm
a) CHE    b) PHE    
c) NAP    d) ANT   
  33 
polymers in solution,44,45 nine dendrons of each type were immerged in a periodic 
simulation box filled with water molecules (Figure 2.11a).  MD simulations were 
carried out at 25 and 5 °C for each system to study aggregation at different 
experimental temperatures. All systems were simulated for 200 ns in NPT conditions. 
During this time, the dendrons self-assembled and all systems reached the 
equilibrium in the MD regime. The evolution of the radius of gyration (Rg) of the 
aggregates, of the PEG chains and of the hydrophobic groups during the MD 
simulations (Figure 2.11) shows that, the aggregates tend to converge to an 
 
 
Figure 2.11: Modeling dendrons self-assembly in solution. (a,c) Starting and 
equilibrated configuration of nine CHE in solution (PEG: blue, dendron scaffold: 
black, CHE: magenta).  (c,d,e) Equilibrated configuration for the PHE (c: red), 
NAP (d: cyan), and ANT (d: green). (b,f,g,h) Radius of gyration (Rg) data of 
different groups of the dendrons as a function of simulation time.c 
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equilibrated configuration where the hydrophilic PEG surrounds the hydrophobic 
groups to minimize the interaction with the solvent. While full reorganization into an 
ideal micelle-like aggregate is awkward for ANT and NAP structures due to the size 
and rigidity of the tail groups (Figure 2.11), ordered stacking of hydrophobic groups 
appears in many regions of the assembly (e.g., green ANT groups). 
Enthalpy H as measured from the MD simulations is a good indicator of 
molecular solubility/hydrophobicity (see SI for comparison with log P).46 According 
to a validated approach,44,45 from the MD simulations we extracted the self-assembly 
enthalpy variations (H) for each system at 5 °C and 25 °C (Table 1). While the H 
values may depend on the flexibility of the different dendron architectures, it is not 
really informative to compare the H of the different systems, but rather it is 
interesting to compare the H of the same system at the two different T: H = H 
(25 °C) – H (5 °C). The H values in Table 2.2 show that some assemblies are 
temperature sensitive and others are not – the more negative is the H value, 
stronger is the interaction between the dendrons in the aggregates at high (25 °C) 
rather than at low temperature (5 °C). 
H is negligible for the more aromatic dendrons (NAP and ANT), whereas it 
is as high as -16 kcal/mol for the non-aromatic dendron CHE. The PHE system seems 
somewhat intermediate, with reduced, yet non-negligible, H (-3.7 kcal/mol), and 
consistent with the temperature-dependent size transition and dendron exchange 
dynamics seen the experiments. In general, hydrophobic aggregation becomes 
stronger at higher T, which is the case for the non-aromatic CHE.  However, the MD 
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data in Table 2.2 show that over a certain level of aromaticity in the hydrophobic 
groups, the dendron interaction into the aggregates is not temperature-sensitive. 
Table 2.2: Self-assembly enthalpies (∆H) of all dendrons at 5°C and 25°C, and 
related variations (∆∆H) expressed in kcal/mol. 
Dendron Rings[a] ∆H(5°C)[b] ∆H(25°C)[b] 
∆∆H = ∆H(25°C) 
- ∆H(5°C) [c] 
CHE 1s -107.3 ± 0.8 -123.3 ± 0.9 -16 ± 1.2 
PHE 1a -91.1 ± 0.8 -94.8 ± 0.6 -3.7 ± 1.1 
NAP 2a -92.1 ± 0.8 -93 ± 1.0 -0.9 ± 1.3 
ANT 3a -95 ± 0.7 -94.4 ± 0.6 0.6 ± 0.9 
[a] Number of rings per-hydrophobic groups (“s”: saturated; “a”: aromatic).  [b] Self-assembly enthalpy 
∆H is calculated as the sum of solute-solute and solute-solvent interactions and is expressed in 
kcal/mol.  [c] ∆∆H provides a measurement of temperature sensitivity of the assemblies. All energies 
values are provided as average ± standard error. 
 
We were then interested in understanding how much of the self-assembly is directly 
imputable to hydrophobic tails of the dendrons: the real structural variables in this 
study. The radial distribution functions, g(r), of the tail groups extracted from the MD 
simulations provide information on the interaction between the hydrophobic groups 
in the assembly (Figure 2.12). The higher and sharper the g(r) peak at short distance, 
the stronger the tail-tail interaction (i.e., coordination, stacking). The related tail- tail 
interaction free energies (∆Etail) reported in Table 2.3 were obtained for all systems 
from the g(r) curves.44 The ∆Etail values show that the tail-tail interaction becomes 
stronger and temperature- insensitive for increasing levels of aromaticity. ∆Etail is 
stronger at 25 °C than at 5 °C only for the non-aromatic system (CHE). 
While the ∆Etail energies include both hydrophobic and aromatic interactions, 
it is interesting to know how much of the tails interaction is directly imputable to the 
aromatic (only short-range) rather than to hydrophobic effects. The short-range 
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aromatic contribution to self-assembly (∆Estack) was calculated as the number of 
stably stacked groups in the assemblies multiplied by the stacking interaction 
energies of CHE, PHE, NAP and ANT groups47 respectively, according to the same 
approach adopted recently to quantify the role of hydrogen bonding in 
supramolecular polymers.48 The remaining part of the tail-tail self-assembly energy 
(∆Etail) was assumed to be imputable to hydrophobic effect (∆Ehyd). This analysis 
provides qualitative insight on the type of interactions in the self-assembly and on 
their modulation in response to temperature change. 
The short-range tail-tail interactions (∆Estack) contribute only by 27-35% to 
the global tail-tail interaction in the CHE system, indicating the predominantly 
hydrophobic nature of the self-assembly in this case (Table 2.3). The long-range 
hydrophobic tail-tail interaction (∆Ehyd), 2-3 times stronger than ∆Estack in CHE, is also 
found to be temperature-sensitive (∆Ehyd: -25.3 vs. -32.3 kcal/mol at 5 and 25 °C 
 
Figure 2.12: Tail-tail self-assembly interaction. (a-d) Radial distribution 
functions – g(r) – of the tail groups respect to each other in the aggregates at 
5°C (blue) and 25°C (red). High and sharp peaks at short distance identify stable 
and strong interaction (coordination/stacking). 
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respectively). Conversely, in the cases where the tail groups are aromatic (PHE, NAP 
and ANT), the short-range interactions (∆Estack) dominate the tails self-assembly 
(Table 2.3: ∆Estack is ≈86%-98% of the total ∆Etail), all terms are found to be 
substantially invariant on temperature changes. These observations clearly suggest 
that the dominance of aromatic interactions in these three dendrons substantially 
reduces the overall temperature sensitivity of these supramolecular assemblies. 
Table 2.3: Tail contribution to self-assembly. The tail-tail interaction free energy 
(∆Etail) for all dendrons at 5°C and 25°C is expressed in kcal/mol. ∆Etail is also 
decomposed further into tail-tail stacking interaction (∆Estack) and tail-tail 
hydrophobic interaction (∆Ehyd). 
Dendron ∆Etail[a] 
 (5°C) 
∆Etail[a]  
(25°C) 
∆Estack[b] 
 (5°C) 
∆Estack[b]  
(25°C) 
∆Ehyd[c] 
 (5°C) 
∆Ehyd[c] 
(25°C) 
CHE -38.9 -44.1 -13.6 (35%) -11.8 (27%) -25.3 (65%) -32.3 (73%) 
PHE -49.6 -50.4 -42.9 (86%) -43.4 (86%) -6.8 (14%) -6.9 (14%) 
NAP -49.7 -49.2 -46.3 (93%) -47.5 (97%) -3.4 (7%) -1.7 (3%) 
ANT -57.6 -55.9 -56.3 (98%) -55.1 (98%) -1.3 (2%) -0.8 (2%) 
[a] ∆Etail values are extracted from the g(r) (see SI).  [b] ∆Estack values are evaluated from the number 
of stably stacked tail groups in the assemblies multiplied for the stacking interaction energies of CHE, 
PHE, NAP and ANT groups.46  [c] ∆Ehyd is calculated as the difference between ∆Etail and ∆Estack. All 
energies are expressed in kcal/mol. 
 
2.6.1 Computational procedure 
The simulation work was conducted using the AMBER 12 software. The 
procedure adopted herein is consistent with that developed recently for studying the 
self-assembly of similar dendrons in water. The molecular models for all dendrons 
were created and parameterized according to a validated procedure for the 
simulation of dendritic molecules (and their pegylated derivatives) interacting with 
biological targets. In particular, CHE, PHE, NAP and ANT dendrons were 
parameterized with the “general AMBER force field (GAFF)” (gaff.dat).  
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Each dendron was immerged in a periodic box extending 14 Å in each 
direction from the dendron atoms and filled with explicit TIP3P water molecules by 
using the leap module of AMBER 12.  After preliminary minimization, all dendron 
systems were initially heated for 50 ps of NVT MD simulation. During this step the 
solute was maintained as fixed.  All restraints were then removed and all dendrons 
were equilibrated through a 200 ns MD simulations under NPT periodic boundary 
conditions at 1 atm of pressure and the experimental temperatures (T) of 25 °C and 
5 °C.  The radius of gyration (Rg) and the root mean square deviation (RMSD) data 
were extracted from the MD trajectories with the ptraj module of AMBER 12 and used 
to assess the equilibration of the systems (Figure 2.13). 
 
According to the same approach adopted previously for similar systems, nine 
copies of the equilibrated (last) configurations of each dendrons were arranged in 
space as shown in Figure 2.11. Each system containing nine dendrons was again 
solvated in a simulation box extending 14 Å in each direction from the dendrons 
atoms and filled with explicit water molecules. After preliminary minimization and 
 
Figure 2.13: Radius of gyration (Rg) and the root mean square deviation 
(RMSD) data as a function of simulation time. 
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heating as described previously, each complex system underwent 200 ns of MD 
simulation in periodic NPT boundary conditions at the experimental temperature of 
25°C (298 K) and 1 atm of pressure.  During this time the dendrons in the systems 
self-assembled, and the complex aggregates reached the equilibrium. Then, 
temperature was decreased to 5°C (278 K) and the systems underwent additional 200 
ns of equilibration in NPT conditions during which the aggregates reached the 
equilibrium in the MD regime also at the lower temperature (see Rg plots in Figure 
2.11). 
All equilibration MD runs used a time step of 2 femtoseconds, the Langevin 
thermostat, and a 10 Å cutoff. The particle mesh Ewald (PME) approach was used to 
treat the long-range electrostatic effects, and the SHAKE algorithm was used on the 
bonds involving hydrogen atoms. All MD simulations were carried out using the 
pmemd.cuda module working on GTX580 GPU cards. 
The last 50 ns of each MD trajectory at both 5°C and 25°C temperatures were 
considered as representative of the equilibrated systems at low and high T, and were 
thus used for further analysis. 
2.6.2 Analysis of Hydrophobicity of Dendrons 
In order to understand what parameter calculated from the MD simulations 
better represents dendrons hydrophobicity, we first performed supplementary MD 
simulations of single hydrophobic moieties (decane, cyclohexane, phenylene, 
naphthalene and antracene) in water. The energy of the different groups in water 
  40 
(enthalpy H) was calculated as the sum of solute-solute and solute-solvent 
interactions according to the MM-PBSA approach. 
H = Egas + Gsol (Eq. 1) 
Enthalpy H is composed of the total gas-phase in vacuo non-bond energy (Egas), 
and of a solvation term (Gsol = GPB + GNP) as described in Eq. 1. The polar component 
of GPB was evaluated using the Poisson-Boltzmann (PB) approach with a numerical 
solver implemented in the pbsa program of AMBER 12.  The non-polar contribution 
to the solvation energy was calculated as GNP = (SASA) +, in which = 0.00542 kcal/Å2, 
= 0.92 kcal/mol, and SASA is the solvent-accessible surface estimated with the MSMS 
program. 
Table 2.4: Gsol and enthapy (H) of the different hydrophobic moieties in water 
calculated from the MD simulations at 5 oC and 25 oC. 
Group 
  Gsol  H  Gsol  H 
log P (kcal/mol) (kcal/mol) (kcal/mol) (kcal/mol) 
  25°C 25°C 5°C 5°C 
Cyclohexane 3.205 1.87 18.4 1.87 17.8 
Phenylene 1.937 0.81 12.6 0.81 12.2 
Naphthalene 3.145 0.87 21 0.87 20.1 
Anthracene 4.304 1 29.2 1 28.1 
 
The log P values of all hydrophobic moieties were calculated through the 
molinspiration web portal (http://www.molinspiration.com/cgi-bin/properties). 
The log P values for all groups were then compared with the energy parameters from 
MD for the hydrophobic groups in water. 
The MD data in Table 2.4 show a remarkable linear trend between the 
hydrophobic groups enthalpy H in water and log P (Figure 2.14: R2≈0.95 at both 
temperatures). This demonstrates that H is a good indicator of the levels of 
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hydrophobicity/solubility of the groups in water, as it was recently demonstrated 
also in in the case of triazine-based dendrimers in solution - and hydrophobic drugs 
in polymer matrices. 
The hydrophobic moieties log P values were also compared to the enthalpy 
Hdend of the entire dendrons, obtained from the same energy analysis described above 
on the equilibrated phase MD trajectory of the single dendrons in water. 
Table 2.5: Gsol and enthapy (Hdend) of the entire dendrons in water at 5 oC and 25 
oC. 
Dendron 
  Gsol-dend  Hdend  Gsol-dend Hdend  
log P (kcal/mol) (kcal/mol) (kcal/mol) (kcal/mol) 
  25°C 25°C 5°C 5°C 
CHE 3.205 -57.7 186.2 -56.7 169.7 
PHE 1.937 -62.2 164.9 -66.9 154.2 
NAP 3.145 -67.9 174.9 -57.5 163.2 
ANT 4.304 -62.2 200.6 -61.1 175.1 
 
Interestingly, data show that also in this case there is a linear trend between 
log P of the hydrophobic groups and Hdend of the dendrons (Figure 2.15). 
 
Figure 2.14: Linear trend between log P and enthalpy H of the individual 
hydrophobic moieties from the MD simulations at T=25°C (a) and T=5°C (b). 
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We also decomposed the dendrons Hdend on a per-residue basis, obtaining the 
Htail values of the hydrophobic moieties when grafted to the dendrons structure and 
in the folded state. Remarkably, the trend between log P and these decomposed Htails 
values for the conjugated groups is again found to be linear (Figure 2.16). This 
demonstrates the crucial role of the hydrophobic groups on the solubility of the entire 
dendrons. In the cases studied herein, the folding and rearrangement of the dendrons 
in solution seem to have minimal impact on the solubility of the hydrophobic groups, 
which appear to influence and control the overall hydrophobicity of the dendrons in 
water. 
Table 2.6: Gsol and enthapy (Htail) of single hydrophobic tail groups only within the 
dendron structures in solution at 5 oC and 25 oC. 
Group 
  Gsol-tail Htail  Gsol-tail Htail 
log P (kcal/mol) (kcal/mol) (kcal/mol) (kcal/mol) 
  25°C 25°C 5°C 5°C 
CHE 3.205 -3.8 11.5 -3.7 10.6 
PHE 1.937 -6.8 6 -6.3 3.4 
NAP 3.145 -8.9 10.9 -8.2 8.1 
ANT 4.304 -7.2 17.7 -7.1 15.7 
 
Figure 2.15: Linear trend between log P of the hydrophobic moieties and 
enthalpy Hdend of the dendrons from the MD simulations at T=25°C (a) and 
T=5°C (b). 
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2.6.3 Analysis of Dendron Self-Assembly 
During the MD simulations of the complex systems, containing 9 dendrons of 
each type, the latters undergo aggregation in solution. The strength of self-assembly 
(ΔH) was calculated from the equilibrated phase MD trajectories with the MM-PBSA 
approach, according to the same procedure adopted in a recent work on the self-
assembly of similar dendrons in water. In particular, as seen in precedence, ΔH is the 
sum of solute-solute and solute-solvent interactions, and it was calculated from the 
equilibrated phase of each MD trajectory (the last 50 ns) at both high (25°C) and low 
T (5°C), obtaining two values: ΔH (25°C) and ΔH (5°C) respectively (see Table 1 in the 
main paper). Temperature sensitivity for each system was then calculated as the 
effect of temperature variation on the strength of self-assembly (Eq. 2): 
ΔΔH = ΔH(25°C) – ΔH(5°C) (Eq. 2) 
The more negative the ΔΔH value, the more temperature-sensitive the system, 
meaning that ΔH is higher (more negative or favorable) at 25°C than at 5°C. Shown in 
 
Figure 2.16: Linear trend between log P and enthalpy Htail of the hydrophobic 
groups grafted to the dendrons scaffold at T=25°C (a) and T=5°C (b). 
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Table 2.2, those systems that are stable across temperature variations have ΔΔH≈0 
(very aromatic systems are not temperature-sensitive). 
We also extracted information on the tail-tail contribution to self-assembly 
directly from the radial distribution functions, g(r), of the tail groups. The tail-tail g(r) 
data (Figure 2.12) provide indication of the relative probability to find tail groups in 
space as a function of the distance and contain information on the interactions 
between the hydrophobic groups in the assemblies. High and sharp g(r) peaks at 
short tail-tail distance are indicators of strong tail-tail interaction (i.e., coordination, 
stacking). The related tail-tail interaction free energies for the different cases  can be 
quantified from the g(r) as: ∆Etail = -kBT ln (g(rpeak)), being the product of the 
Boltzmann constant kB and the temperature T equal to kBT ≈ 0.6 kcal mol-1 at room 
temperature. 
The ∆Etail tail-tail interaction free energies include both hydrophobic and 
aromatic interactions. In our case, we were interested to obtain information, even 
qualitative, on how much of the tail-tail interaction was directly imputable to the 
aromatic (short-range only), rather than to long-range hydrophobic effects. The 
short-range aromatic contribution to self-assembly (∆Estack) was calculated using the 
same approach recently adopted to quantify the effect of hydrogen bonding in 
supramolecular polymers. Namely, we counted the number of stably stacked 
hydrophobic groups in the different assemblies within a distance <5 Å – maximum 
stacking distance (T-shape) for the CHE, PHE, NAP and ANT groups – and multiplied 
this number by the characteristic stacking interaction energies of the CHE, PHE, NAP 
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and ANT (Table 2.7). The remaining part of the global tail-tail self-assembly energy 
(∆Etail) was then assumed to be imputable to hydrophobic effect: ∆Ehyd = ∆Etail – ∆Estack. 
Table 2.7: Short-range tail-tail interaction energies (∆Estack) at 5 oC and 25 oC. 
∆Estack values are calculated as the number of stacked tail groups multiplied by 
the stacking energy of each group. 
Group 
Avg. n° of Tail 
Stacked Groups 
(5°C) 
Avg. n° of Tail 
Stacked Groups 
(25°C) 
Group Stacking 
Energy  
(kcal/mol) 
∆Estack[b] 
 (5°C) 
∆Estack[b]  
(25°C) 
  
CHE 4.3 3.6 -3.0922 -13.3 -11.2 
PHE 13.6 13.0 -2.8222 -38.4 -36.7 
NAP 12.1 12.2 -3.623 -43.6 -44.0 
ANT 12.1 11.8 -4.7623 -56.3 -55.1 
2.7 Conclusions 
In summary, we have systematically probed the hydrophobic moiety of 
the facially amphiphilic dendron while keeping the hydrophilic component 
unchanged in order to understand the influence of aromatic functional groups 
in controlling the temperature-responsive behavior of amphiphilic assemblies. 
Our combined experimental-theoretical approach provides a multiscale 
picture of these self-assembled materials in solution. We demonstrate that the 
inclusion of an increasing degree of aromaticity in the hydrophobic moieties of 
the self-assembling dendrons produces temperature-insensitive 
supramolecular assemblies, regardless of the level of the side chain 
hydrophobicity. On the other hand, when the hydrophobic groups of the 
dendrons lack aromaticity, the self-assembly is mainly controlled by 
hydrophobic interactions and the supramolecular material possesses a 
temperature-sensitive behavior. This study demonstrates how subtle changes 
in the self-assembling structures can produce different structural and dynamic 
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properties on the supramolecular material. As amphiphilic assemblies are 
pursued in a variety of applications that require kinetic stability, such as in drug 
delivery or sensing, the design guidelines that emanate from this study will 
have broad implications. 
2.8 Experimental Details 
2.8.1 Synthesis and Characterization 
All chemicals and reagents were purchased from commercial sources and 
were used as received, unless otherwise mentioned. 1H NMR spectra were recorded 
on a 400 MHz Bruker NMR spectrometer using the residual proton resonance of the 
solvent as the internal standard. Chemical shifts are reported in parts per million 
(ppm). When peak multiplicities are given, the following abbreviations are used: s, 
singlet; bs, broad singlet; d, doublet; t, triplet; m, multiplet. 13C NMR spectra were 
proton decoupled and recorded on a 100 MHz Bruker spectrometer using the carbon 
signal of the deuterated solvent as the internal standard. FAB-MS spectra were 
measured on a JEOL JMS700. MALDI-TOF spectra were measured on a Bruker 
MicroFlex. Compound 1-8 and Pyr were synthesized according to the previously 
reported procedures.40,41. 
2.8.1.1 General procedure for conversion of bromo to azido 
To a solution NaN3 (5.0 equiv) of in acetonitrile was added appropriate bromo 
functionalized compound (1.0 equiv) and reaction mixture has been left under reflux 
condition for 16 hours. The solvent was then evaporated under vacou. The crude 
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product obtained was treated with water and extracted three times with ethyl 
acetate. The organic layer was dried over Na2SO4, and evaporated to dryness. 
2.8.1.2 General procedure for ‘click’ reaction 
To the mixture of dendritic acetylene compound 8 (1.0 equiv) and azido 
functionalized compound (9-12) (9.0 equiv) in 0.5 mL of THF was added the mixture 
of CuSO4.5H2O (1.0 equiv) and sodium ascorbate (1.0 equiv) in 0.5 mL of water at 
room temperature. The reaction mixture was stirred at 50 ºC for 48 hours. The 
reaction was monitored using thin layer chromatography (TLC). After complete 
disappearance of compound 9, the resultant crude was added water and extracted 
three times with ethyl acetate. The organic layer was dried over NaSO4 and 
evaporated to dryness. The crude product was purified by silica gel column 
chromatography. 
2.8.1.3 Synthesis of compound 9 
 
To a solution of NaN3 (2.33 g, 35.85 mmol) in 20 mL acetonitrile was added 1-
(bromomethyl)cyclohexane (1.0 mL, 7.17 mmol) and the reaction mixture was 
refluxed at 65 oC for 16 hours. Solvent was evaporated under vacuo and crude 
product obtained was then extracted three times with ethyl acetate. Organic layer 
was dried over NaSO4 and evaporated to dryness to yield 0.79 g (79%) of compound 
9. 1H NMR (400 MHz, CDCl3)  3.26 (d, J = 6.4 Hz, 2H), 1.87-1.83 (m, 2H), 1.75-1.71 
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(m, 2H), 1.66-1.57 (m, 2H), 1.30-1.11 (m, 3H), 1.03-0.92 (m, 2H). Spectral values are 
in agreement with reported procedure.49 
2.8.1.4 Synthesis of compound 10 
 
To a solution of NaN3 (2.72 g, 41.80 mmol) in 20 mL acetonitrile was added 
benzyl bromide (1.0 mL, 8.36 mmol) and the reaction mixture was refluxed at 65 oC 
for 16 hours. Solvent was evaporated under vacuo and crude product obtained was 
then extracted three times with ethyl acetate. Organic layer was dried over NaSO4 and 
evaporated to dryness to yield 0.68 g (62%) of compound 10. 1H NMR (400 MHz, 
CDCl3)  7.42-7.32 (m, 5H), 4.35 (s, 2H). Spectral values are in agreement with 
reported procedure.50 
2.8.1.5 Synthesis of compound 11 
 
2-(bromomethyl)naphthalene (1.0 g, 4.52 mmol) and NaN3 (1.47 g, 22.61 
mmol) were dissolved in 15 mL acetonitrile and reaction mixture was refluxed at 65 
ºC for 16 hours. Solvent was evaporated under vacuo and crude product obtained was 
then extracted three times with ethyl acetate. Organic layer was dried over NaSO4 and 
evaporated to dryness to yield 0.82 g (99%) of compound 11. 1H NMR (400 MHz, 
CDCl3)  7.89-7.78 (m, 4H), 7.52-7.42 (m, 3H), 4.51 (s, 2H). Spectral values are in 
agreement with reported procedure.49 
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2.8.1.6 Synthesis of compound 12 
 
9-anthracenemethanol (0.5 g, 2.40 mmol) was dissolved in 40 mL of 1:1 
acetonitrile/dichloromethane mixture and cooled to 0 ºC. TEA (0.50 mL, 3.60 mmol) 
and MsCl (0.23 mL, 3.0 mmol) were added through syringe to the solution and 
reaction mixture was stirred at room temperature for 4 hours. This crude mixture 
was then neutralized with 15 mL of hydrochloric acid (1N) and organic layer was 
washed twice with water and once with brine. Residue was dried over NaSO4 and 
evaporated under vacuo. To a solution of resultant solid in 25 mL of DMF was added 
NaN3 (0.47 g, 7.2 mmol) and the reaction mixture was refluxed at 65 ºC for 16 hours. 
Solvent was evaporated under vacuo and crude product obtained was then extracted 
three times with ethyl acetate. Organic layer was dried over NaSO4 and evaporated to 
dryness. Crude product was purified with silica gel column chromatography to yield 
0.40 g (71%) of compound 12. 1H NMR (400 MHz, CDCl3)  8.51 (s, 1H), 8.30 (d, J = 
8.8 Hz, 2H), 8.06 (d, J = 8.4 Hz, 2H), 7.6 (m, 2H), 7.52 (m, 2H) 5.33 (s, 2H); EI-MS m/z 
calculated for C15H11N3 233.27; Found: 233.10. Spectral values are in agreement with 
reported procedure.51 
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2.8.1.7 Synthesis of compound CHE 
 
To the mixture of dendritic acetylene compound 8 (30 mg, 0.023 mmol) and 
compound 9 (29 mg, 0.208 mmol) in 0.5 mL of THF was added the mixture of 
CuSO4.5H2O (5.7 mg, 0.023 mmol) and sodium ascorbate (4.5 mg, 0.023 mmol) in 0.5 
mL of water at room temperature. The reaction mixture was stirred at 50 ºC for 48 
hours. The reaction was monitored using thin layer chromatography (TLC). After 
complete disappearance of compound 9, the resultant crude was added water and 
extracted three times with ethyl acetate. The organic layer was dried over NaSO4 and 
evaporated to dryness. The crude product was purified by silica gel column 
chromatography to yield 36 mg (91%) of compound CHE. 1H NMR (400 MHz, acetone-
d6)  8.00 (s, 2H), 7.69 (s, 1H), 6.92-6.58 (m, 11H), 5.18 (s, 4H), 5.11 (s, 2H), 5.04 (s, 
4H), 4.65 (s, 2H), 4.24 (d, J = 7.2 Hz, 4H), 4.15-4.04 (m, 8H), 3.82-3.80 (m, 4H), 3.66-
3.42 (m, 50H), 3.27-3.26 (m, 9H), 1.94-1.83 (m, 2H), 1.80-1.47 (m, 17H), 1.24-0.96 (m, 
14H). 13C NMR (100 MHz, CDCl3)  160.2, 159.7, 159.1, 157.1, 156.3, 142.7, 139.7, 
136.1, 123.3, 119.7, 110.5, 106.5, 106.3, 105.4, 101.1, 100.9, 72.0, 70.9, 70.7, 70.7, 
70.6, 70.6, 70.5, 69.9, 69.7, 69.7, 68.8, 67.6, 65.2, 63.7, 62.3, 59.1, 56.7, 56.5. MALDI-
TOF m/z calculated for C90H135N9O24: 1727.11; Found: 1727.49. 
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2.8.1.8 Synthesis of compound PHE 
 
To the mixture of dendritic acetylene compound 8 (30 mg, 0.023 mmol) and 
compound 10 (27 mg, 0.203 mmol) in 0.5 mL of THF was added the mixture of 
CuSO4.5H2O (5.7 mg, 0.023 mmol) and sodium ascorbate (4.5 mg, 0.023 mmol) in 0.5 
mL of water at room temperature. The reaction mixture was stirred at 50 ºC for 48 
hours. The reaction was monitored using thin layer chromatography (TLC). After 
complete disappearance of compound 10, the resultant crude was added water and 
extracted three times with ethyl acetate. The organic layer was dried over NaSO4 and 
evaporated to dryness. The crude product was purified by silica gel column 
chromatography to yield 35 mg (90%) of compound PHE. 1H NMR (400 MHz, acetone-
d6)  8.04 (s, 2H), 7.74 (s, 1H), 7.39-7.21 (m, 15H), 6.90-6.55 (m, 11H), 5.61 (s, 4H), 
5.50 (s, 2H), 5.16 (s, 4H), 5.09 (s, 2H), 5.00 (s, 4H), 4.64 (s, 2H), 4.12-4.02 (m, 6H), 
3.80-3.77 (m, 4H), 3.63-3.40 (m, 50H), 3.25-3.24 (m, 9H). 13C NMR (100 MHz, CDCl3) 
 160.2, 159.6, 159.0, 157.1, 156.5, 142.8, 139.7, 136.1, 132.1, 119.7, 114.4, 110.5, 
106.5, 106.2, 105.5, 101.1, 72, 70.9, 70.8, 70.7, 70.6, 70.5, 70.5, 69.9, 69.7, 69.7, 68.9, 
67.6, 62.2, 59.1, 55.7, 53.6, 50.6, 31.9, 29.6, 29.5, 29.4, 29.1, 26.6, 22.7, 14.2. MALDI-
TOF m/z calculated for C90H117N9O24 1708.96; Found: 1709.45. 
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2.8.1.9 Synthesis of compound NAP 
 
To the mixture of dendritic acetylene compound 8 (30 mg, 0.023 mmol) and 
compound 11 (38 mg, 0.207 mmol) in 0.5 mL of THF was added the mixture of 
CuSO4.5H2O (5.7 mg, 0.023 mmol) and sodium ascorbate (4.5 mg, 0.023 mmol) in 0.5 
mL of water at room temperature. The reaction mixture was stirred at 50 ºC for 48 
hours. The reaction was monitored using thin layer chromatography (TLC). After 
complete disappearance of compound 11, the resultant crude was added water and 
extracted three times with ethyl acetate. The organic layer was dried over NaSO4 and 
evaporated to dryness. The crude product was purified by silica gel column 
chromatography to yield 42 mg (96%) of compound NAP. 1H NMR (400 MHz, 
acetone-d6)  8.06 (s, 2H), 7.87-7.68 (m, 13H), 7.52-7.29 (m, 9H), 6.90-6.50 (m, 11H), 
5.75 (s, 4H), 5.63 (s, 2H), 5.14 (s, 4H), 5.07 (s, 2H), 4.94 (s, 4H), 4.63 (s, 2H), 4.07-3.98 
(m, 6H), 3.75-3.73 (m, 4H), 3.61-3.38 (m, 50H), 3.24-3.21 (m, 9H). 13C NMR (100 MHz, 
CDCl3)  191, 164.8, 160.2, 159.6, 159, 157.1, 156.5, 142.9, 139.8, 139.2, 138.3, 136.1, 
132.1, 131.0, 130.1, 129.9, 128.9, 128.1, 119.7, 114.4, 110.6, 106.6, 106.2, 105.6, 
105.6, 105.5, 101.5, 72, 70.9, 70.7, 70.6, 70.5, 69.9, 69.7, 67.6, 65.2, 62.2, 59.1, 53.6, 
31.9, 30.4, 30.1, 29.8, 29.7, 29.6, 29.5, 29.4, 29.3, 29.1, 29, 26.6, 26.5, 25.9, 22.7, 14.2. 
MALDI-TOF m/z calculated for C102H123N9O24: 1859.14; Found: 1859.21. 
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2.8.1.10 Synthesis of compound ANT 
 
To the mixture of dendritic acetylene compound 8 (30 mg, 0.023 mmol) and 
compound 12 (48 mg, 0.206 mmol) in 0.5 mL of THF was added the mixture of 
CuSO4.5H2O (5.7 mg, 0.023 mmol) and sodium ascorbate (4.5 mg, 0.023 mmol) in 0.5 
mL of water at room temperature. The reaction mixture was stirred at 50 ºC for 48 
hours. The reaction was monitored using thin layer chromatography (TLC). After 
complete disappearance of compound 12, the resultant crude was added water and 
extracted three times with ethyl acetate. The organic layer was dried over NaSO4 and 
evaporated to dryness. The crude product was purified by silica gel column 
chromatography to yield 45 mg (92%) of compound ANT. 1H NMR (400 MHz, 
acetone-d6)  8.59-8.25 (m, 8H), 8.06-7.88 (m, 6H), 7.70-7.39 (m, 16H), 6.80-6.39 (m, 
17H), 4.97 (s, 4H), 4.88 (s, 2H), 4.81 (s, 4H), 4.56 (s, 2H), 3.99-3.93 (m, 6H), 3.70-3.34 
(m, 54H), 3.24-3.18 (m, 9H). 13C NMR (100 MHz, CDCl3) 



 MALDI-TOF m/z calculated for C114H129N9O24: 2009.32; Found: 2009.83. 
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2.8.2 Preparation of Dendron Assemblies 
Stock solution (100 µM) of each dendrimer was prepared by dissolving the 
dendrimer in milli-Q water at room temperature. Solutions were sonicated for 3 
hours and stirred at 4 oC for one week ahead of any experiment. Dendrimer solutions 
were diluted to required concentrations before each experiment. 
2.8.3 Dynamic Light Scattering (DLS) Measurements 
The size distribution of the aggregates was determined by Malvern Zetasizer 
(Nano-ZS). For each DLS experiment, 100 µM solution was diluted to 25 µM and 
filtered through 0.45 µm filter. Hydrodynamic radius (DH) of the dendritic assembly 
was measured at different temperatures with 7 minutes of equilibration time to 
achieve desired temperature before each measurement and repeated in triplicate. 
Size distribution, correlograms and PDI for all samples can be found in the supporting 
information (Figure S1, Figure S2, Figure S3 and Table S1). 
2.8.4 Critical Aggregation Concentration (CAC) Measurement 
The CACs of the dendrons in aqueous solutions were determined using the 
fluorescence intensity of Nile red (λem= 620 nm), which is non-covalently 
encapsulated in dendron aggregate (Figure S4). 1.5 mL of 100 μM stock solution of 
each dendron was added 150 L of Nile red (10% wt) stock solution in acetone. 
Mixture was stirred open to the air without cap overnight to remove organic solvent. 
Once all the acetone is removed, 1 mL solution was transferred to a cuvette and 
emission spectrum (λex= 530 nm) of Nile red was taken as the concentration was 
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gradually diluted with water. The emission intensity vs concentration of dendron was 
plotted and CAC values are determined by interception between two best fitted 
horizontal and vertical lines 
2.8.5 Dye Encapsulation and Guest Exchange Study 
To a vial containing 1.2 mL of 25 µM dendrimer solution added 2 µL of 0.77 
mg/mL pyrene (in acetone) and perylene (in acetone) separately, followed by 
evaporation of acetone by leaving the vial uncapped for 30 minutes while stirring at 
room temperature. After 30 min, the vial is capped, and solution was stirred for 24 
hours at room temperature. FRET experiments were performed on a JASCO (PF-
6500) spectrofluorimeter and UV-Vis spectra were collected using a Cary-100 scan 
spectrophotometer. FRET measurements started as soon as pyrene and perylene 
containing dendrimer solutions (25 µM) were mixed (1:1 by volume). Pyrene was 
excited at 339 nm, pyrene and perylene emission were monitored at 375 and 447 nm 
respectively for the calculation of FRET ratio. 
2.8.6 Time-Dependent Fluorescence and Host Exchange 
Time-lapse studies were performed on a PTI Quantamaster-30 
phosphorescence/fluorescence spectrofluorimeter with a xenon flash power supply 
and TC125 temperature controller. Host exchange experiment of each dendron (CHE, 
PHE, NAP, and ANT) with pyrene dendrimer, Pyr, was performed at 5 °C, 10 °C, 25 °C 
and 40 °C. Dendrimer solutions (25 µM) were pre-equilibrated at target temperature 
±1 °C for 30 min prior to mixing. 0.5 mL of Pyr solution was added to a fluorescence 
cuvette in a thermoelectric cuvette holder and allowed to equilibrate. 0.5 mL of CHE 
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was added through syringe directly into the cuvette and emission at 379 nm was 
monitored with time. Instrument parameters were adjusted at 339 nm for excitation 
and 379 nm for emission. Sample was being stirred at low rpm during the 
measurement. Same procedure was followed for all other dendrons (PHE, NAP, and 
ANT). 
2.8.7 NMR Spectra 
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CHAPTER 3 
 EFFECT OF AROMATIC FUNCTIONAL GROUPS ON ENCAPSULATION 
EFFICIENCY OF POLYMER NANOGELS  
3.1 Introduction 
The first successful demonstration of chemotherapy treatment using small 
molecule active agents were reported in late 1940s.1,2 Since then, numerous 
chemotherapeutic agents have been discovered and it has become one of the most 
commonly applied cancer treatment today. Although survival rate of cancer patients 
significantly improved with this treatment modality, side effects of chemotherapy are 
immensely harmful.3–6 In addition to severe physiological consequences, it causes 
psychological trauma as most of the patients suffer from hair loss. These toxic side 
effects are the results of non-specific biodistribution of chemotherapeutic agents, 
which don’t discriminate between tumor and healthy tissue. Accordingly, the efficacy 
of drug is significantly dampened due to the limited dosage that leads to narrow 
therapeutic indices. At the same time, small molecule agents are rapidly cleared from 
the circulation without allowing sufficient drug accumulation at the tumor site. 
Another main problem associated with chemotherapeutic agents is that many of them 
have poor water solubility which requires careful formulation for systemic 
administration. These drawbacks underscored the need for advanced drug delivery 
system that overcomes these hurdles associated with conventional approach.7 
Since 1970s, nanotechnology has been applied to medicine and fostered the 
development of nanoparticle based therapeutic delivery approach.8 Shortly after, the 
major breakthrough in drug delivery came with the increasing realization that the 
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nanometer sized (10-100 nm) large particles permeated through the tumor 
vasculature via enhanced permeability and retention (EPR) effect, and resulted in 
increased accumulation of nanoparticles at tumor site owing to the prolonged 
circulation time in the system.9–11 It has been shown that the circulation time of 
nanoparticles have been improved by surface Peg-ylation, which renders “stealth” 
nature to the system, decreases the non-specific interaction with proteins and 
mitigates the clearance via mononuclear phagocyte system (MPS).12,13 Early research 
and development of nanoparticle delivery systems focused on liposomal formulation 
of anthracyclines and FDA granted the approval of first liposomal doxorubicin drug 
in 1995, branded as Doxil®. Concurrently, numerous delivery platforms have 
emerged as potential nanomedicine, which provide improved solubility and 
protection of therapeutic payload, enhanced delivery, controlled release and reduced 
toxicity. To date, there are 51 FDA-approved nanomedicines available in the market 
while 77 candidates are in clinical trials.14 Clear advantage over traditional 
chemotherapy has been demonstrated with versatile delivery platforms including 
liposomes, polymers, dendrimers and inorganic particles.15–20  
Among all, polymeric systems, particularly the ones consisting of hydrophilic 
and lipophilic functionality are ideal for the development of drug delivery vehicle 
since they self-assemble into core-shell type micellar structures that are capable of 
sequestering hydrophobic drugs within the core and protecting the payload with its 
hydrophilic shell.21–23 In addition to the ideal size for tumor accumulation, polymeric 
systems carry a great structural flexibility to be tailored for multiple purposes such 
as targeting, peg-ylation and biocompatibility.24 However, recent studies revealed 
  65 
that the efficient clinical translation of polymer micelle based nanomedicines are 
interrupted by lack of efficacy, mainly because of low loading capacity and decreased 
drug retention related to poor in vivo stability.25,26 Micelle formation is a dynamic 
process controlled by the non-covalent interactions and aggregate form of micelle is 
only available at polymer concentration above its critical micelle concentration 
(CMC). During systemic administration, concentration of polymer is diluted to ~25 
times, which triggers the disassembly of polymer micelle within the circulation and 
leads to premature drug release before reaching the target site. Several strategies 
have been proposed to overcome these shortcomings, such as core or shell cross-
linking, covalent drug-attachment, incorporating electrostatic, aromatic, 
hydrophobic, host-guest interactions.27 Recently, there is a growing interest in 
crosslinked polymer nanogel systems that hold a potential to negate both 
encapsulation stability and loading efficiency problems to further advance the field of 
nanomedicine.28–31  
Our group has reported the versatile delivery platform based on polymer 
nanogel system that offers desired characteristics for ideal delivery vehicle.32–34 
Crosslinked polymer nanogel comprised of simple PEG-PDS, p(PEGMA-co-PDSMA), 
random copolymer exhibits size tunable micellar aggregate with excellent guest 
encapsulation stability. One pot formulation involving drug encapsulation, covalent 
crosslinking and surface functionalization with multiple targeting ligands without 
extensive purification process makes this system significantly advantageous over 
conventional heterogenous polymerization techniques such as emulsion and inverse-
emulsion. Both crosslinking and the subsequent surface modification processes are 
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strictly controlled and quantified by the disulfide exchange reaction between 
deficient amount of externally added thiol and PDS groups. We also have 
demonstrated the stimuli-responsive guest release properties in reducing 
environment by exploiting the degradable feature of disulfide crosslinked network. 
However, there is an ample room for development in the technology to be further 
translated into clinics, particularly in terms of drug loading efficiency as well as 
biocompatibility. Besides being a handle for crosslinking and post-functionalization, 
PDS groups are responsible for keeping the inner core hydrophobic for drug 
retention. But, as it is being consumed during the crosslinking reaction, the amount 
of PDS groups are decreasing and eventually it could lead to potential drug leakage. 
Moreover, PDS groups are shown to be cytotoxic according to in vitro cell viability 
assays. Therefore, it is necessary to generate alternative system that negate these 
shortcomings yet keep the inherent practicality of PEG-PDS polymer. Recently, 
several reports have shown that the incorporation of aromatic side chain into the 
hydrophobic block of polymer micelle have facilitated high loading of anticancer drug 
as well as an increased micellar stability via pi-pi stacking interaction.35–37 We also 
have showed that the guest exchange dynamics have significantly affected by the 
nature of hydrophobic side chain in PEG-based amphiphilic assemblies. Systematic 
study based on variation of hydrophobic side chain revealed that the aromatic 
functional group improves the encapsulation stability of guest molecules via aromatic 
interaction.38  
In this study, we designed a series of polymeric nanogels that carry the same 
versatility as PEG-PDS polymer, but with a superior loading efficiency and 
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substantially less cytotoxicity. Triblock random copolymers with GRAS components 
of phenyl or naphthyl groups in place of PDS generated the stable nanoassembly with 
increased drug retention owing to the pi-pi staking interaction between inter/intra 
polymer side chains and the aromatic drug entity. To obtain insights into the 
relationship between polymer and drug structures, four different drug molecules 
with varying log P values were tested (Figure 3.2). Drug encapsulation efficiencies 
and loading capacities were quantified using high performance liquid 
chromatography (HPLC) and found to be as high as 90% and 27% respectively. 
Potential use of newly developed nanogels as drug delivery vehicle has been 
demonstrated by in vitro cell viability assay on HeLa cell line. 
 
Figure 3.1: (a) Structure of the polymer precursor and polymer nanogel. (i) 
Drug encapsulation and micelle formation in water. (ii) Nanogel formation via 
crosslinking of PDS groups with DTT. (b) Schematic representation of 
preparation of drug encapsulated nanogel  
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3.2 Molecular Design, Synthesis and Characterization 
Key characteristics for versatile drug delivery vehicle are: (i) tunable and 
desirable particle size; (ii) simple and efficient drug encapsulation; (iii) stable 
encapsulation and in vivo drug retention; (iv) stimuli-responsive drug release; (v) 
tunable release kinetics; (vi) biocompatibility; and (vii) facile synthesis and 
formulation. Original design of PEG-PDS polymer nanogel exhibits many of these 
characteristics with great deal of synthetic flexibility. Thus, subtle improvement in 
the nanogel performance can be made conveniently. Conventional PEG-PDS random 
copolymer consists of 30:70 molar ratio of PEG and PDS moiety and forms stable 
micellar assemblies in aqueous environment with decent size distribution. At the 
same time, it has been studied that the ~20% crosslink density would hold the drug 
stably inside the nanogel without leakage, leaving ~80% PDS groups for retaining the 
hydrophobic interior. Based on these findings, we designed a new series of polymers 
 
Figure 3.2: (a) Synthesis of PEG-PDS (30:70 mol%) polymer, PDS. (b) Structure 
of target polymers PHE, BNZ and NAP. 
PHE BNZ NAP
PDS
a)
b)
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that contain PEG, PDS and aromatic side chain, where PDS will be utilized for 
crosslinking and further surface modification. Polymer structures and preparation of 
nanogels are shown in Figure 3.1 and Figure 3.2. Three different random copolymers 
with phenyl (PHE), benzoyl (BNZ), and naphthoyl (NAP) functional groups have been 
prepared by reversible addition-fragmentation chain transfer (RAFT) 
polymerization, having PEG and PDS-methacrylates as comonomers. We included 
PEG-PDS polymer for comparison in this study, which is denoted as PDS. Each 
polymer was synthesized in high yield with >90% conversion. Polymer structures 
Table 3.1: Properties of polymers and size of polymers assemblies. 
polymer Mn (PDI)a 
Comonomer composition Size (nm) 
(PDI)
d 
(OEG:PDS:X)
b (OEG:PDS:X)c 
PDS  21 300 (1.59) 30:70:00 32:68e 22 (0.452)  
PHE 27 900 (1.19) 30:20:50 32:16:52 8 (0.221) 
BNZ 28 200 (1.18) 30:20:50 34:15:51 8 (0.118) 
NAP 27 200 (1.14) 30:20:50 33:15:52 13 (0.192) 
aMeasured by GPC (THF). bMonomer feed ratios and X stands for corresponding monomer. cActual 
ratios determined by NMR. dSize distribution is measure via dynamic light scattering. 
 
Figure 3.3: GPC trace of PDS, PHE, BNZ and NAP. 
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were confirmed with the 1H NMR analysis (Figure 3.4). Average molecular weights of 
these polymers were estimated by GPC analysis with PMMA standard and found to be 
within similar range with narrow polydispersity as listed in Table 3.1 and Figure 3.3. 
We tested the loading efficiency of polymer nanogels using different types of 
commercially available drugs that have varying hydrophobicity and aromaticity (log 
P values and number of rings) as shown in Figure 3.5. Three of them are clinically 
well-established cancer chemotherapeutic agents. Doxorubicin (DOX), is a well-
known inhibitor of cell replication through its interaction with DNA. It causes severe 
cardiotoxicity when used without liposomal carrier. There are several FDA approved 
liposomal formulations of DOX for various cancer treatment. However, half of the 
patients suffer from side effects caused by in vivo drug leakage, which underscores 
the need for a stable drug carrier for this drug. Next, we included two of taxane-
derivatives, docetaxel (DTX) and paclitaxel (PTX), which are mitotic inhibitors. They 
 
Figure 3.4: Characterization of polymers with 1H NMR spectra. 
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exhibit high therapeutic efficacy against many solid tumors. Unfortunately, clinical 
applications of these drugs are fairly impeded because of the lack of suitable drug 
delivery system. Lastly, immunosuppressant and anticancer agent, rapamycin (RAP) 
was involved in this study to demonstrate the versatility of the nanocarrier, which in 
future can be used for targeting immune cells to fight growing immune disorders. 
3.3 Nanogel Formation and Drug Encapsulation 
One of the greatest advantages of our nanogel system is the extreme simplicity 
of preparation. Simple dissolution of polymer in water with mild sonication yields 
uniform-size nanoassemblies with good correlation function. Each polymer formed 
stable polymeric micelle at room temperature. According to dynamic light scattering 
 
Figure 3.5:Structure of the drugs and the relevant properties. 
Docetaxel Paclitaxel RapamycinDoxorubicin
Drug Water 
solubility
logP
(exper.)
logP
(calc.)
pKa Number 
of rings
Route
Doxorubicin (DOX) soluble 1.27 1.41 9.53 5 IV
Docetaxel (DTX) insoluble 2.4 2.59 10.96 6 IV
Paclitaxel (PTX) insoluble 3 3.2 10.36 7 IV
Rapamycin (RAP) insoluble 4.3 4.85 9.96 4 Oral
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(DLS) measurement, polymers PDS, PHE, BNZ and NAP showed assemblies of 22, 8, 
8 and 13 nm hydrodynamic diameter in water, respectively (Figure 3.6)  
3.3.1 Formation of DOX-Loaded Nanogels 
DOX is a fairly water soluble chemotherapeutic agent as compared to other 
hydrophobic drugs used in this study, particularly when it is in HCl salt form (H2O 
soluble: 50 mg/mL). Practically, commercially available DOX·HCl is neutralized with 
triethylamine to make it less water soluble and then formulated into polymer 
micelles. Though physically entrapped hydrophobic DOX easily leaks from the 
nanoparticulate carriers since it still bears some water solubility. In this study, we 
 
Figure 3.6: Size distribution of polymer assembly; (a) PDS, (b-d) Volume%, 
intensity % and number % average size of PHE, BNZ and NAP. 
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envisaged that the stability of DOX encapsulation will be improved by pi-pi stacking 
interaction between drug and the aromatic side chain of polymeric micelles. After 
thorough experimentation, optimum encapsulation methodology of DOX into PEG-
PDS nanogels has been developed and employed in this study. Polymeric micelles 
prepared in NaSCN solution had better DOX encapsulation capability in comparison 
to the water formulation. This could be due to the increased size of polymer 
assemblies in the presence of chaotropic anion (SCN-) via salting-in effect. It has been 
previously reported that the aggregation properties of PEG-PDS polymer assemblies 
are affected by the Hofmeister ions and the size of nanogel is significantly increased 
due to the interchain crosslinking of loose polymer aggregates after the addition of 
 
Figure 3.7: Size distribution of polymer assembly and DOX-loaded nanogels by 
intensity %; (a) PDS, (b) PHE, (c) BNZ, (d) NAP. 
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dithiol crosslinker, dithiothreitol (DTT).39 In this case, polymer assemblies were 
prepared in 100 mM NaSCN solution and yielded slightly large aggregates compared 
to the ones prepared in H2O. After micelle formation, hydrophobic DOX is directly 
added to the mixture and stirred in the dark for a week. DOX-loaded polymer micelles 
were crosslinked with addition of DTT and dialyzed extensively to remove non-
encapsulated free drug. Size of DOX-loaded nanogels were significantly larger than 
the size of initial polymer aggregate. For example, the size of NAP increased to 136 
nm, whereas the size of polymer aggregate was 29 nm before DOX loading. Similarly, 
the size of PDS raised from 28 to 92 nm and the size of BNZ reached to 127 nm from 
only 16 nm. We observed the smallest size increase in PHE case, where the size went 
up to 42 nm from 15 nm originally. Whether there is an effect of these size changes 
on encapsulation efficiency or not is discussed in drug quantification part.  
3.3.2 Formation of DTX-loaded, PTX-loaded, and RAP-loaded Nanogels 
In the case of hydrophobic drugs (DTX, PTX and RAP), encapsulation was 
achieved using dialysis method, in which the formation of polymer micelles and drug 
encapsulation happens simultaneously while mixture of drug and polymer in organic 
solvent is being dialyzed against water. Slow process of micellization during the 
exchange of dimethylformamide (DMF) and water across the dialysis membrane 
allowed sufficient amount of drug encapsulation without bulk precipitation, even at 
high drug feed (30 wt %). Remarkably, amount of drug encapsulation did not change 
after crosslinking although the overall hydrophobicity of polymer micelle is 
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decreased as PDS groups are consumed. Crosslinking reaction is monitored by the 
absorption spectrum of reaction mixture, tracing the signature peak of 2-
pyrithothione at 341 nm, which is a stable byproduct of corresponding disulfide 
exchange reaction. As shown in Figure 3.8, all polymer micelles are successfully 
crosslinked and formed drug-loaded nanogels according to the appearance of new 
 
Figure 3.8: (a) DTT crosslinking reaction and the formation of nanogel. (b-e) 
UV spectroscopy of empty polymer assembly and crosslinked nanogels loaded 
with drug; (b) PDS, (c) PHE, (d) BNZ, (e) NAP. 
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peak at 341 nm. Formation of 2-pyridothione is not very clear in case of NAP nanogel 
due to the peak overlap with absorption of naphthyl groups. However, increase in the 
absorption indicates the formation of 2-pyridothione since there is no additive 
absorption peak associated with any of the drug. As we planned, complete 
crosslinking of PHE, BNZ and NAP was achieved whilst partial crosslinking of PDS 
was done to match with other polymers.  
DLS analysis revealed that the size of nanogels was found to be larger than the 
original polymer assemblies after drug encapsulation compared to empty nanogels, 
which was previously observed for polymeric micelle based drug delivery vehicles 
 
Figure 3.9: Size distribution of drug-loaded nanogels; (a) PDS, (b) PHE, (c) BNZ, 
(d) NAP. 
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(Figure 3.9 and Table 3.2).35,36 Overall size change of polymer micelle vs. drug loaded 
nanogels are shown in Figure 3.10. 
Table 3.2: Size distribution of empty polymer micelles and drug-loaded nanogels. 
Polymer 
 Size by Z-Avg (nm) (PDI) 
 
Empty polymer 
assembly 
DTX-loaded 
nanogel 
PTX-loaded 
nanogel 
RAP-loaded 
nanogel 
PDS 22 (0.452)  26 (0.230) 23 (0.185) 64 (0.196) 
PHE 8 (0.221) 12 (0.227) 24 (0.403) 18 (0.197) 
BNZ 8 (0.118) 12 (0.185) 21 (0.491) 20 (0.163) 
NAP 13 (0.192) 31 (0.325) 36 (0.185) 87 (0.229) 
3.4 Drug Quantification of DOX-loaded Nanogels 
Drug encapsulation efficiency (EE) and loading capacity (LC) of DOX-loaded 
nanogels were determined by UV-vis spectrometry since DOX has a distinct 
absorption peak at 497 nm. Extinction coefficient of hydrophobic DOX is 
experimentally calculated in water as well as in ethanol, which is a reasonable 
approximation of nanogel interior (Figure 3.11). The extinction coefficient in water 
 
Figure 3.10: Size change of empty polymer micelle vs drug-loaded nanogels; 
(a) DOX, (b) DTX, PTX and RAP. 
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was determined to be 6170 M-1cm-1 whereas the extinction coefficient in ethanol was 
found to be 9510 M-1cm-1. Solubility of hydrophobic DOX was much better in ethanol 
than water, therefore the value determined in ethanol was utilized for calculation of 
EE(%) and LC(%). 
𝐸𝐸(%) =  
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑖𝑛 𝑛𝑎𝑛𝑜𝑔𝑒𝑙
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑎𝑑𝑑𝑒𝑑
× 100 
𝐿𝐶(%) =  
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑖𝑛 𝑛𝑎𝑛𝑜𝑔𝑒𝑙
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑛𝑎𝑛𝑜𝑔𝑒𝑙
× 100 
DOX-loaded nanogels were diluted to 0.1 mg/mL concentration for the UV 
absorption spectroscopy measurement for the evaluation of drug loading. Loading 
capacity of PDS nanogel was determined to be 1.4% with encapsulation efficiency of 
9.3%. There is a clear improvement in DOX encapsulation for aromatic polymers, 
particularly for BNZ and NAP, in which the LC % increased to about 1.5 times for BNZ 
and 3.35 times for NAP. Additionally, DOX-loaded nanogels exhibited remarkable 
drug retention and encapsulation stability, which hasn’t been observed for PDS 
nanogels. This result suggests that the increase in the rigidity of polymer nanoparticle 
 
Figure 3.11: (a) Concentration dependent UV absorption of hydrophobic DOX 
in ethanol. (b) Standard calibration curve of DOX in water and ethanol. 
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via aromatic interaction indeed improved the DOX encapsulation efficiency as well as 
DOX encapsulation stability. Surprisingly, there was no appreciable encapsulation of 
DOX for PHE polymer even though it has similar hydrophobicity as BNZ and PDS. One 
reason for this could be the slightly small molecular volume compared to BNZ and 
Table 3.3: DOX encapsulation efficiency and loading capacity 
polymer DOX feed 
(wt%) 
Polymer 
(mg) 
DOX 
feed (mg) 
DOX loaded 
(mg) EE% LC% 
PDS 15% 30 4.5  0.42  9.3% 1.4% 
PHE 15% 30 4.5 0.18  4% 0.6% 
BNZ 15% 30 4.5  0.63  14.0% 2.1% 
NAP 15% 30 4.5  1.41  31.3% 4.7% 
 
 
Figure 3.12: UV absorption spectroscopy of empty polymer assembly and DOX-
loaded nanogels; (a) PDS, (b) PHE, (c) BNZ, (d) NAP. 
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PDS, which also contributes to the overall hydrophobicity. This makes the volume of 
hydrophobic groups less than BNZ and PDS, as such decreasing the capability of DOX 
encapsulation. 
3.5 Drug Quantification of DTX-loaded, PTX-loaded, RAP-loaded Nanogels 
Since the absorption peaks of DTX, PTX and RAP are interfered by polymer 
absorption range, UV-Vis was not suitable as a drug quantification tool. We chose to 
use HPLC, which is a common analytical instrument for accurate drug quantification. 
By using a standard calibration curve specific to each drug molecule, amount of drug 
encapsulated within the nanocarrier can be calculated. Figure 3.13 shows the 
experimentally generated standard curves for each drug. 
 
Figure 3.13: HPLC standard calibration curve; (a) DTX, (b) PTX and (c) RAP. 
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Each drug was encapsulated using dialysis method and the non-encapsulated 
excess drug was precipitated spontaneously at ambient condition. Measuring the 
exact amount of drug entrapped within the nanogel was challenging. After several 
failures of various methods such as ultrafiltration, inverse-filtration and extraction, 
we chose to analyze the non-encapsulated excess drug instead of nanogel-entrapped 
drug. Non-encapsulated hydrophobic drug was easily precipitated and pelleted at the 
bottom of Eppendorf tube after centrifugation. The pellet was dissolved in organic 
solvent and quantified by HPLC after repeated washing cycle. Overall drug 
encapsulation efficiency results are listed in Table 3.4 and shown in Figure 3.14 
after careful drug quantification.  
Table 3.4: Drug EE% and LC% of all polymers with DTX, PTX and RAP. 
Polymer 
DTX  PTX   RAP  
EE % LC %  EE % LC %  EE % LC % 
PDS 99 29.9  72.5 21.7  64 19.2 
PHE 100 30  83.8 25.1  64 19.2 
BNZ 97.6 29.3  32.5 9.7  64 19.2 
NAP 92.7 27.8  99.3 29.8  62.7 18.8 
 
Figure 3.14: Drug load all polymers; (a) EE%, (b) LC%. 
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According to our measurements, most of the polymers exhibited remarkable 
drug loading content of >19% except PTX encapsulation of BNZ was found to be as 
low as 9.7%. In general, there is a noticeable trend in encapsulation efficiency 
depending on hydrophobicity of drugs. DTX, which is less hydrophobic than PTX and 
RAP, was encapsulated very efficiently into all polymers with more than 90% of EE 
and 27% of LC, whereas the encapsulation of PTX and RAP is slightly lower than DTX. 
Also, the encapsulation efficiency of PTX was higher than that of RAP for most of the 
polymers apart from low EE% of PTX with BNZ. This means that the hydrophobicity 
of drug plays an important role for the encapsulation efficiency and it is dictated by 
the compatibility of drug molecules with the hydrophobic side chains of polymer 
nanogels. In most cases, there is not much difference in loading efficiency in terms of 
varying polymer structures. This could be due to the very similar hydrophobicity of 
aromatic side chains. The only case we observed the appreciable increase in drug 
encapsulation efficiency in aromatic nanogels was for the loading of PTX in NAP 
nanogel, which was about 99%, compared to that of BNZ, which was around 32%. We 
believe this increase is certainly due to the increased aromatic stacking interaction of 
naphthyl groups. 
3.6 Effect of Drug-loaded Nanogels on Cell Viability 
To demonstrate therapeutic efficacy of drug-loaded nanogels, in vitro cell 
viability assays were performed in comparison to empty nanogels and free drugs. The 
cytotoxicity of each formulation was evaluated against HeLa cells by using MTT assay. 
Cell viability test of free drugs and empty polymer nanogels were conducted as 
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important controls in our study. All cell viability results are depicted in Error! 
Reference source not found.. We did not observe significant cytotoxicity from 
empty nanogels in each case for a concentration up to 200 g/mL. Also, none of the 
free drugs caused high cytotoxicity for up to 1000 nM, which is about 0.58, 0.81, 0.85 
and 0.91g/mL concentration of DOX, DTX, PTX and RAP, respectively. The reason 
for the low efficacy of free drug is because of the low solubility of these agents in 
aqueous environment. Each drug is added to the cell media dissolved in small amount 
of DMSO to perform cell study. This solubility related issue once again underscores 
the need for appropriate drug carrier to cellular environment without loss of efficacy. 
Cell viability of drug-loaded nanogels are categorized in terms of the drug cargo and 
shown in one graph as a percentage live cells vs. polymer concentration. As we 
expected, cell-killing activity of DOX-loaded nanogels were very poor compared to 
other drug-loaded nanogels since the encapsulation efficiency of DOX was quite low 
in all polymers. Even so, the highest cell killing of about 18% was observed from NAP, 
which presented the highest DOX loading of 4.7% among all the nanogels mostly 
attributed to the pi-pi stacking interaction. 
The encapsulation of DTX was excellent for all nanogels and it resulted in 
about 30% loading of drug for each polymer. Consequently, all DTX-loaded nanogels 
showed 50% of cell killing at concentration of 20 g/mL in a similar manner, whereas 
there was no significant toxicity relevant to the empty nanogels. We also observed 
concentration dependent cell killing effect rather than dependence on polymer 
structures since the cell viability test assesses the efficacy of drug encapsulated 
within nanocarrier, which was almost the same for all nanogels. At the same time, this 
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result supports the fact that the drug quantification method we have developed is 
 
 
 
Figure 3.15: Cell viability of HeLa cells cultured with free drugs, empty polymer 
nanogels and drug-loaded nanogels. 
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reliable. 
Encapsulation of PTX is challenging with many different polymer carriers. We 
obtained the highest amount of PTX encapsulation in NAP nanogel with 29% of LC 
and the drug efficacy of PTX-loaded NAP nanogels was found to be much higher 
compared to other polymer nanogels. There is ~40% cell kill at 0.2 g/mL of polymer 
concentration, which is about 7 nM in terms of drug concentration and the cell 
viability reaches ~50% with 2 g/mL of polymer concentration, in which the drug 
concentration is only about 0.06 g/mL (70 nM). Considering the cell viability of free 
PTX, where there was no cell killing effect up to 100 nM, this result clearly indicates 
that the drug efficacy had dramatically increased when it is delivered to cells in the 
form of nanogel formulation, particularly with naphthyl functionalized nanogel. All 
other PTX-loaded nanogels showed concentration dependent cytotoxicity having 
~50% cell killing effect at 200 g/mL polymer concentration. 
Cytotoxicity of RAP-loaded nanogels were determined to be increasing with 
increased polymer concentration in case of PDS and BNZ nanogels and the cell 
viability reached to ~50% at nanogel concentration of 200 g/mL, where the drug 
concentration is ~1.4  Surprisingly, RAP-loaded NAP and PHE nanogels exhibited 
only 30% cell killing effect on HeLa cells at this concentration even though they carry 
similar amount of drug.  
3.7 Conclusion 
We have successfully developed nanogel-based drug delivery system that 
shows enhanced drug encapsulation and drug retention by means of aromatic 
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interaction. A series of nanogel forming amphiphilic polymers that contain non-toxic 
aromatic side chains were synthesized and their loading capacity and cellular 
toxicities were assessed with four different potent anticancer drugs. Effortless 
synthesis, simple surface functionalization and stable drug encapsulation made these 
nanoparticles attractive carrier for poorly water soluble therapeutic agents. Overall, 
polymer nanogels showed excellent drug encapsulation capability, having the highest 
EE of 92% for DTX and the lowest EE of 62% for RAP. Based on our evaluations, we 
have observed that the efficacy of drug is undoubtedly improved with nanogel 
formulation and the cell-killing effect is depending on drug concentration. Loading of 
DOX and PTX was significantly improved by the incorporation of pi-pi stacking 
interaction into the nanogel system. With the use of aromatic functional groups, 
encapsulation efficiency as well as the encapsulation stability of DOX is notably 
increased. Cytotoxicity of PTX was dramatically improved when it is formulated in 
nanogels, particularly with highly aromatic NAP polymer nanogel. Finally, we have 
demonstrated the drug-stabilizing aspect of pi-pi stacking interaction for micelle-
based drug delivery platform using nanogel system. These versatile polymer nanogels 
hold great promise for therapeutic delivery. Future research will be devoted to the 
investigation of in vitro drug release and in vivo delivery with targeting ligands. 
3.8 Experimental Details 
3.8.1 Synthesis and Characterization 
All chemicals and reagents were purchased from commercial sources and 
were used as received, unless otherwise mentioned. Poly(ethylene glycol) methyl 
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ether methacrylate (PEGMA; 500), 2,2′-dithiodipyridine, 2,2′-azobis(2-
methylpropionitrile) (AIBN), 4-cyano-4-(phenylcarbonothioylthio)pentanoic acid 
(CTA), DL-dithiothreitol (DTT), 2-hydroxyethyl methacrylate (HEMA), phenethyl 
alcohol, benzoyl chloride, 2-naphthoyl chloride, triethylamine (TEA) were obtained 
from Sigma-Aldrich. AIBN was purified by recrystallization in cold methanol for three 
times before use. Docetaxel (DTX) and paclitaxel (PTX) were purchased from TCI 
America. Doxorubicin hydrochloride (DOX·HCl) and rapamycin (RAP) were 
purchased from AvaChem Scientific. Pyridyl disulfide ethyl methacrylate (PDSMA) 
was synthesized according to previously reported procedure.40 1H NMR spectra were 
recorded on a 400 MHz Bruker NMR spectrometer using the residual proton 
resonance of the solvent as the internal standard. Chemical shifts are reported in 
parts per million (ppm). When peak multiplicities are given, the following 
abbreviations are used: s, singlet; bs, broad singlet; d, doublet; t, triplet; m, multiplet. 
Molecular weight of the polymer was estimated by gel permeation chromatography 
(GPC), using THF as eluent and poly(methyl methacrylate) (PMMA) as a standard 
with a refractive index detector. Dynamic light scattering (DLS) measurements were 
performed using a Malvern Nanozetasizer-ZS. UV-Visible absorption spectra were 
recorded on Perkin Elmer Lambda 35 UV/Vis Spectrometer.  
3.8.1.1 Synthesis of pyridyl disulfide ethyl methacrylate (PDSMA) 
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To a solution of pyridyl disulfide ethyl alcohol (3.17 g, 16.9 mmol) in dry 
dichloromethane (25 mL) under argon TEA (2.8 mL, 20.3 mmol) was added dropwise 
at 0oC. After stirring of 10 min in ice bath, methacryloyl chloride (1.8 mL, 18.6 mmol) 
was slowly added to the reaction mixture dropwise and left for stirring at room 
temperature. After stirring of 4 hours, reaction mixture was washed with saturated 
NaHCO3 three times and with brine once. Organic layer was dried over anhydrous 
Na2SO4 and evaporated to dryness. Crude mixture was purified with flash column 
chromatography to obtain pure monomer as light-yellow oil in 89% yield. 1H NMR 
(400 MHz, CDCl3)  8.47 (d, 1H), 7.70-7.61 (m, 2H), 7.10 (t, 1H), 6.12 (s, 1H), 5.58 (s, 
1H), 4.40 (t, 2H), 3.09 (t, 2H), 1.93 (s, 3H). Spectral values are in agreement with 
previous report.33 
3.8.1.2 Synthesis of 2-phenylethyl methacrylate 
 
To a solution of phenethyl alcohol (5.6 g, 45.8 mmol) in dry dichloromethane 
(40 mL) under argon TEA (7.0mL, 50.4 mmol) was added dropwise at 0oC. After 
stirring of 10 min at ice bath, methacryloyl chloride (5.4 mL, 54.9 mmol) was slowly 
added to the reaction mixture dropwise and left for stirring overnight at room 
temperature. After stirring of 16 hours, reaction mixture was washed with saturated 
NaHCO3 three times and with brine once. Organic layer was dried over anhydrous 
Na2SO4 and evaporated to dryness. Crude mixture was purified with flash column 
chromatography to obtain pure monomer as light-yellow oil in 91% yield. 1H NMR 
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(400 MHz, CDCl3)  7.32-7.28 (m, 4H), 7.24-7.20 (m, 1H), 6.03 (s, 1H), 5.59 (s, 1H), 
4.33 (t, J = 6.8 Hz, 2H), 2.98 (t, J = 6.8 Hz, 2H), 1.88 (s, 3H). Spectral values are in 
agreement with previous report.41 
3.8.1.3 Synthesis of 2-(benzoyloxy)ethyl methacrylate 
 
To a solution of HEMA (5 g, 38.4 mmol) in dry dichloromethane (40 mL) under 
argon, TEA (5.4 mL, 38.4 mmol) was added dropwise at 0oC. After stirring of 10 min 
at ice bath, benzoyl chloride (3.81 mL, 32.8 mmol) in 40 mL of dry dichloromethane 
was added to the reaction mixture and left for stirring overnight at room temperature. 
After stirring of 20 hours, triethylammonium salt was filtered and the reaction 
mixture was washed with water three times. Organic layer was dried over anhydrous 
Na2SO4 and evaporated to dryness. Crude mixture was purified with flash column 
chromatography to obtain pure monomer as colorless oil in 80% yield. 1H NMR (400 
MHz, CDCl3)  8.02 (d, J = 7.8 Hz, 2H), 7.64 (t, J = 7.4 Hz, 1H), 7.51 (t, J = 7.6 Hz, 2H), 
6.09 (s, 1H), 5.61(s, 1H), 4.60 (t, J = 4.5 Hz, 2H), 4.53 (t, J = 4.3 Hz, 2H), 1.91 (s, 3H). 
13C NMR (100 MHz, CDCl3) 167.2, 166.4, 136.0, 133.2, 130.0, 129.7, 128.5, 126.1, 
62.5, 18.3. 
3.8.1.4 Synthesis of 2-(naphthoyloxy)ethyl methacrylate 
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To a solution of HEMA (5 g, 38.4 mmol) in dry dichloromethane (40 mL) under 
argon TEA (5.4 mL, 38.4 mmol) was added dropwise at 0oC. After stirring of 10 min 
at ice bath, benzoyl chloride (6.3 g, 32.8 mmol) in 40 mL of dry dichloromethane was 
added to the reaction mixture and left for stirring overnight at room temperature. 
After stirring of 20 hours, triethylammonium salt was filtered and the reaction 
mixture was washed with water three times. Organic layer was dried over anhydrous 
Na2SO4 and evaporated to dryness. Crude mixture was purified with flash column 
chromatography to obtain pure monomer as white crystal in 85% yield. 1H NMR (400 
MHz, CDCl3)  8.65 (s, 2H), 8.09-7.98 (m, 4H), 7.68-7.60 (m, 2H), 6.11 (s, 1H), 5.62(s, 
1H), 4.66 (t, J = 4.5 Hz, 2H), 4.56 (t, J = 4.5 Hz, 2H), 1.92 (s, 3H). 13C NMR (100 MHz, 
CDCl3) 167.3, 166.6, 136.1, 135.7, 132.6, 131.4, 129.5, 128.5, 128.3, 127.9, 127.2, 
126.8, 126.2, 125.3, 62.9, 62.6, 18.4. 
3.8.1.5 Synthesis of PDS Polymer 
To a 10 mL Schlenk-flask, PEGMA (1.28 g, 2.56 mmol), PDSMA (1.53 g, 5.98 
mmol), 4-cyano-4-(phenylcarbonothioylthio)pentanoic acid (26.5 mg, 0.095 mmol), 
and recrystallized AIBN (3.1 mg, 0.019 mmol) were mixed in dry THF (4.5 mL). The 
reaction mixture was subjected to three cycles of freeze-pump-thaw. The sealed flask 
was immersed in a preheated oil bath at 70 °C and stirred for 24 hours. The 
polymerization reaction was stopped by immersing the flask in liquid nitrogen. 
Product was purified with extensive dialysis against DCM:MeOH (3:1, v/v) for three 
days. Yield: 90%. GPC (THF) Mn:21300 Da. Ð:1.59. 1H NMR (400 MHz, CDCl3): 8.45, 
7.69, 7.13, 4.27, 4.06, 3.62-3.53, 3.46, 3.36, 3.02, 1.93-1.82, 1.04-0.89. 13C NMR (100 
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MHz, CDCl3):177.4, 176.5, 159.6, 150.0, 137.6, 125.9, 121.3, 120.1, 72.0, 70.6, 68.6, 
64.2, 62.8, 59.1, 54.2, 45.0, 36.9, 18.9, 17.2. 
3.8.1.6 Synthesis of PHE Polymer 
To a 10 mL Schlenk-flask, PEGMA (1.17 g, 2.35) mmol), PDSMA (0.4 g, 1.57 
mmol), 2-phenylethyl methacrylate (0.75 g, 3.92 mmol), 4-cyano-4-(phenylcarbono-
thioylthio)pentanoic acid (24.3 mg, 0.087 mmol), and recrystallized AIBN (2.9 mg, 
0.017 mmol) were mixed in dry THF (4.5 mL). The reaction mixture was subjected to 
three cycles of freeze-pump-thaw. The sealed flask was immersed in a preheated oil 
bath at 70 °C and stirred for 24 hours. The polymerization reaction was stopped by 
immersing the flask in liquid nitrogen. Product was purified with extensive dialysis 
against DCM:MeOH (3:1, v/v) for three days. Yield: 91%. GPC (THF) Mn:27900 Da. 
Ð:1.19. 1H NMR (400 MHz, CDCl3): 8.48, 7.80, 7.32, 4.30-4.13, 4.37-3.58, 3.47, 3.29, 
3.18, 2.98, 2.82, 1.85, 1.08-0.88. 13C NMR (125 MHz, CDCl3):177.1, 176.3, 159.5, 
159.3, 149.7, 137.7, 137.3, 136.2, 126.7, 125.8, 121.0, 120.0, 71.9, 70.6, 68.5, 65.5, 
63.9, 62.6, 59.0, 54.1, 53.5, 45.1, 44.8, 36.9, 34.7, 18.7, 18.3, 17.0. 
3.8.1.7 Synthesis of BNZ Polymer 
To a 10 mL Schlenk-flask, PEGMA (1.17 g, 2.35) mmol), PDSMA (0.4 g, 1.57 
mmol), 2-(benzoyloxy)ethyl methacrylate (0.92 g, 3.92 mmol), 4-cyano-4-(phenyl-
carbonothioylthio)pentanoic acid (24.3 mg, 0.087 mmol), and recrystallized AIBN 
(2.9 mg, 0.017 mmol) were mixed in dry THF (4.5 mL). The reaction mixture was 
subjected to three cycles of freeze-pump-thaw. The sealed flask was immersed in a 
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preheated oil bath at 70 °C and stirred for 24 hours. The polymerization reaction was 
stopped by immersing the flask in liquid nitrogen. Product was purified with 
extensive dialysis against DCM:MeOH (3:1, v/v) for three days. Yield: 92%. GPC (THF) 
Mn:28200 Da. Ð:1.18. 1H NMR (400 MHz, CDCl3): 8.47, 8.07, 7.78-7.54, 7.21, 4.54-
4.09, 3.58, 3.47, 3.29, 3.11, 2.83, 1.89, 1.11-0.98. 13C NMR (125 MHz, CDCl3):177.1, 
176.2, 171.2, 166.1, 159.3, 149.7, 137.3, 133.3, 129.7, 128.5, 121.0, 120.0, 71.9, 70.6, 
68.4, 63.9, 62.9, 62.7, 62.1, 60.4, 59.0, 54.2, 53.5, 45.1, 44.8, 36.7, 21.1, 18.9, 17.0, 14.3.  
3.8.1.8 Synthesis of NAP Polymer 
To a 10 mL Schlenk-flask, PEGMA (1.17 g, 2.35) mmol), PDSMA (0.4 g, 1.57 
mmol), 2-(naphthoyloxy)ethyl methacrylate (1.11 g, 3.92 mmol), 4-cyano-4-(phenyl-
carbonothioylthio)pentanoic acid (24.3 mg, 0.087 mmol), and recrystallized AIBN 
(2.9 mg, 0.017 mmol) were mixed in dry THF (4.5 mL). The reaction mixture was 
subjected to three cycles of freeze-pump-thaw. The sealed flask was immersed in a 
preheated oil bath at 70 °C and stirred for 24 hours. The polymerization reaction was 
stopped by immersing the flask in liquid nitrogen. Product was purified with 
extensive dialysis against DCM:MeOH (3:1, v/v) for three days. Yield: 93%. GPC (THF) 
Mn:27200 Da. Ð:1.14. 1H NMR (400 MHz, CDCl3): 8.59, 8.41, 8.00-7.58, 7.14, 4.54-
4.08, 3.59, 3.26, 2.84, 1.92, 1.06. 13C NMR (125 MHz, CDCl3):177.1, 176.3, 166.2, 
159.3, 149.5, 137.4, 135.6, 132.4, 131.3, 129.5, 128.4, 128.3, 127.8, 126.8, 125.2, 
121.0, 119.9, 72.0, 70.6, 68.4, 63.8, 62.9, 62.3, 60.4, 59.1, 54.3, 52.8, 45.2, 44.9, 36.8, 
21.1, 19.0, 17.1, 14.3. 
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3.8.2 NMR Analysis  
Figure 3.16: 1H NMR spectrum of pyridyl disulfide ethyl methacrylate. 
 
Figure 3.17: 1H NMR spectrum of 2-phenethyl methacrylate. 
 
Figure 3.18: 1H NMR spectrum of 2-(benzoyloxy)ethyl methacrylate. 
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Figure 3.19: 13C NMR spectrum of 2-(benzoyloxy)ethyl methacrylate. 
 
 
 
Figure 3.20: 1H NMR spectrum of 2-(naphthoyloxy)ethyl methacrylate. 
 
 
 
 
Figure 3.21: 13C NMR spectrum of 2-(naphthoyloxy)ethyl methacrylate. 
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Figure 3.22: 1H NMR spectrum of PDS polymer. 
 
 
 
Figure 3.23: 13C NMR spectrum of PDS polymer. 
 
 
Figure 3.24: 1H NMR spectrum PHE polymer. 
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Figure 3.25: 13C NMR spectrum PHE polymer. 
 
 
 
Figure 3.26: 1H NMR spectrum of BNZ polymer. 
 
 
 
Figure 3.27: 13C NMR spectrum of BNZ polymer. 
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3.8.3 Preparation of Hydrophobic DOX 
Commercially available hydrophilic form of DOX, DOX·HCl, was neutralized 
with TEA and converted to hydrophobic form. DOX·HCl was sonicated in a solution of 
methanol in chloroform (12.5% v/v) with 1.5 molar equivalents of TEA and then 
stirred at room temperature for three hours without light exposure. The mixture was 
filtered using a 0.45 μm syringe filter and remaining solvent was evaporated under 
 
Figure 3.28: 1H NMR spectrum of NAP polymer. 
 
 
 
Figure 3.29: 13C NMR spectrum of NAP polymer. 
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vacuum. DOX was stored at -20°C, protected from light, until loading into polymer 
micelles. 
3.8.4 Drug Encapsulation (DOX) 
Polymer was dissolved in 100 mM NaSCN solution and stirred overnight at 
room temperature to form stable micellar aggregate of 30 mg/mL concentration. To 
1mL of polymer solution in NaSCN, 6 mg (20% wt feed) of hydrophobic DOX was 
added as a crystal and sonicated for 30 min and then left for stirring in the dark for 7 
days at room temperature. 
3.8.5 Drug Encapsulation (DTX, PTX and PAR) 
Polymer (50 mg) and drug (15 mg, 30% wt feed) were dissolved in 6 ml of 
DMF. This mixture is transferred into cellulose dialysis bag (7000 MWCO tubing, 22 
mm circular internal diameter) and dialyzed against water at room temperature for 
4 days with frequent water change. After dialysis, drug-loaded polymer micelle 
solution was transferred back to empty vial with multiple rinse with water. Final 
concentration of polymer is reconstituted to 4 mg/mL. 
3.8.6 Crosslinking and Drug-loaded Nanogel 
To a vial containing 3 mL of 4mg/mL polymer solution that had previously 
encapsulated drug molecule, we added 10 µL of 0.06 mg/mL DTT solution. 
Crosslinking reaction was monitored with the UV absorption spectrometer by 
following the absorption maximum of byproduct, 2-pyridothione, at 341 nm. 
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Crosslink density was calculated by using the molar extinction coefficient of 
byproduct (8.08*103 M-1cm-1 at 341 nm). 
3.8.7 Drug Quantification Method by HPLC 
1 mL of drug-loaded nanogel solution in Eppendorf tube was centrifuged for 5 
min at 6000 g. After centrifugation, non-encapsulated hydrophobic drug was 
precipitated at the bottom and 0.9 mL of nanogel solution was removed carefully 
without disturbing the drug pellet and replaced with water. This cycle was repeated 
for three times to remove drug that is encapsulated in nanogel. Then the drug pellet 
was dissolved in 0.1 mL of acetone and measured by HPLC. 
3.8.8 Cell Culture 
HeLa (human cervical adenocarcinoma) were obtained from the American 
Type Culture Collection (ATCC ID: CCL-2). Cells were cultured in Dulbecco’s Modified 
Eagle’s medium/F12 (DMEM/12) supplemented with 2 mM L-glutamine, 10 µg/mL 
streptomycin, 100 U/mL penicillin and 10% (v/v) fetal bovine serum (FBS) at 37 °C 
in a humid atmosphere of 10% CO2. When HeLa cells were grown to 90% confluency, 
cells were trypsinized for 5 mins in PBS and passaged 1:10 into a new tissue culture 
plate. Maximum number of passage was limited to 10 for HeLa cells. DMEM/F12 and 
supplements were obtained from ThermoFisher.  
3.8.9 Cell Viability: MTT assay 
For cell viability assay, HeLa cells were trypsinized and counted. Cells were 
seeded on flat bottom 96-well tissue culture plates at a density of 7,000 cells/well and 
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rested for 24 hours at 37 °C in 10% CO2. After overnight incubation, the culture 
medium was removed, and cells were treated with empty or drug-loaded nanogel 
samples at different concentrations in complete medium for 24 hours. After 
treatments, cells were washed, and fresh medium was added. Cells were incubated 
with the fresh medium for further 24 hours. Next day, medium was replaced with 3-
(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium solution (MTT) (prepared as 1 
mg/ml in medium) and cells were incubated for 3-4 hours at 37 °C to allow the 
formation of the MTT formazan. 96-well plate was spinned for 5 minutes to let the 
formazan settle at the bottom of the plate. MTT medium was discarded and formazan 
was dissolved in 100 µL of DMSO. Purple color formation was observed and recorded 
using a plate reader at 540nm. 
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CHAPTER 4 
 19F MRI IMAGING OF THERANOSTIC POLYMER NANOGEL WITH IMPROVED 
SEGMENTAL MOBILITY OF EMBEDDED FLUORINE MOIETIES 
4.1 Introduction 
Development of noninvasive cellular and molecular imaging techniques is a 
growing area of interest in current clinical and biomedical research. Detection of 
disease biomarkers at an early stage combined with an image-guided therapeutic 
delivery platform would grant tremendous possibility to save many patient lives. 
Magnetic resonance imaging (MRI) is one of the most widely used noninvasive 
imaging modalities. It provides high spatial resolution and excellent deep tissue 
contrast without exposure to ionizing radiation or radioactive labeled tracers.1,2 In 
conventional MRI, image contrast is created by the distinct relaxation properties of 
protons associated with water molecules within different tissues. However, the 
relative insensitivity due to the low relaxivity of proton necessitates the use of 
paramagnetic contrast agents (CAs) such as Gd3+ chelates and super paramagnetic 
iron oxide (SPIO) nanoparticles (NPs).3–6 These CAs serve as relaxation enhancers by 
decreasing both longitudinal or spin-lattice (T1) and transverse or spin-spin (T2) 
relaxation time of protons in surrounding water molecules, thus improving the 
sensitivity by shortening the acquisition time. Although contrast-assisted 1H MRI 
shows exquisite performance in anatomical and pathological imaging, it presents a 
challenge during molecular imaging and cell tracking when subtle change in image 
contrast is complicated by the large background signal from mobile water molecules.7  
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19F MRI is an emerging field that holds great promise in multimodal imaging 
of targeted drug delivery and cell therapy.8,9 The 19F nucleus exhibits excellent NMR 
sensitivity, owing to its favorable magnetic properties close to that of 1H, but with 
essentially no detectable background signal in human body. Thus, the signal intensity 
is directly correlated to the fluorinated probe and the anatomical localization of 
fluorine labeled particles or cells can be identified precisely when it is superimposed 
with 1H density image.10,11 19F MRI-based quantitative cell tracking gained significant 
interest after the initial proof-of principle demonstration in vivo using cell tracking of 
immune cells with perfluorocarbon (PFC) nanoemulsion.12–14 PFCs are highly 
hydrophobic, chemically and biologically inert organic compounds so that in vivo 
administration requires careful formulation of PFC with synthetic and natural 
emulsifiers.10,15 Recently, oil-in-water formulation of perfluoropolyether (PFPE) with 
biocompatible surfactants has been commercialized for use in in vivo cell tracking 
and trafficking.16 However, complex formulation, droplet instability, prolonged 
retention time in the body and the lack of multi-functional property have limited their 
potential applications in targeted therapeutics and theranostics.9 Polymeric CAs 
present advantage in terms of attaining high fluorine content with sharp 19F NMR 
peak, which is necessary for obtaining reduced chemical shift image artifacts, and 
thus high sensitivity.9,43 In this vein, recent efforts have focused on developing 
polymeric 19F MRI CAs as multimodal imaging probes. A variety of polymeric tracers 
have been developed and tested, including linear polymers,17–24 star polymers,25,26 
dendritic polymers,27–29 hyperbranched polymers (HBPs),30–34 and polymer nanogels 
(NGs).35–37 In addition, several groups have devoted efforts to develop activatable 
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“smart” agents that provide on-off 19F signal in response to certain environmental 
changes, such as pH, redox potential, enzymes and non-enzymatic proteins.22,35,38–42 
The key challenge in fully realizing the potential of polymeric tracers for these 
applications arises from the fact that fluorocarbon substitutions render segments of 
polymers hydrophobic, which leads to aggregation. This aggregation process has 
deleterious effect on their use in 19F MRI applications. An ideal polymeric tracer 
should possess relatively short T1 relaxation time for minimum scan time and 
sufficiently long T2 relaxation time for high signal intensity. Both T1 and T2 relaxation 
times are influenced by molecular motion, particularly T2. Spin-spin relaxation time 
of fluorine is sensitive to spatial arrangements and mobility of the nuclear spins since 
it is defined by the dipolar coupling between near neighboring 19F and 1H nuclei. 
Consequently, fluorine signal intensity is significantly attenuated in an aqueous 
environment due to the aggregation-induced loss of molecular mobility and the 
subsequent decrease in T2 relaxation time.44 Therefore, performance of excellent 
polymeric tracer is characterized by the capability of accommodating maximum 
amount of fluorine moiety in aqueous environment without compromising the 
segmental mobility of 19F nuclei by keeping the fluorine-fluorine interaction at a 
minimum.9,45 
Considerable efforts have been taken to elucidate the fundamental design 
criteria to develop well performing polymeric tracers for 19F MRI. Partially 
fluorinated HBPs that form core-shell type micellar assemblies in water have been 
shown to be applicable in 19F MRI as well as in drug delivery.30,33 Also, an effect of 
backbone chain flexibility on mobility of 19F nuclei on fluorinated polymers has been 
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demonstrated showing that polymers with low Tg possess  better imaging properties 
(acrylates are better than methacrylates).17 Also, statistical random copolymers and 
branched polymers confer well separated fluorine segments rather than block 
copolymers, yet high degree of branching can lead to increased rigidity and restricted 
segmental motion.44 Briefly, tweaking this fine balance between fluorine content and 
segmental mobility requires careful design characteristics. Several groups have 
reported a strategy to improve the motion of fluorine segments in polymeric systems 
by incorporating charged monomers to attain electrostatic repulsion, which led to 
swelling and the subsequent size increase or conformational changes in polymeric 
particles, thus providing enhanced 19F signal intensity.18,25,35 Recently, Fuchs et al. 
demonstrated the switch on in T2 relaxation time of HBP upon the release of 
covalently incorporated hydrophobic drug molecule.34 Despite these exciting 
advances, significant improvements in T2 are still required for practical use in in vivo 
applications.  
We envisaged an approach in which the one can take advantage of hydrophobic 
properties of the fluorocarbon substitutes to self-assemble amphiphilic polymers into 
nanoscale aggregates, the fluorocarbon-bearing interior density of which is manipulated in 
a post-assembly step. Such a strategy consists of three steps: (a) formation of polymeric 
assembly with high fluorocarbon core, along with degradable hydrocarbon moieties; (b) 
preservation of the assembly through chemical crosslinking; (c) triggered degradation of 
cleavable hydrocarbon parts to decrease the density of the assembly’s interior. We show 
here that such an assembly exhibits increased T2 relaxation time and results in enhanced 
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signal intensities in 19F NMR and 19F MRI phantom imaging. In vivo MRI imaging 
capability of these nanogels were also assessed using mouse models. 
4.2 Molecular Design and Synthesis 
Consistent with the strategy outlined above, we designed an amphiphilic 
random copolymer that consists of crosslinkable and degradable hydrophobic 
functional groups along with the fluorocarbon probe. Our approach to generate 
interior flexibility of amphiphilic assembly was based on preserving the morphology 
through chemical crosslinking first and then degrading and removing the cleavable 
portions from the interior of the crosslinked nanogel. To achieve this, we used the in 
situ crosslinking based nanogel formation strategy.46,47 We ascertained that 
incorporation of up to 30% of the hydrophilic oligoethylene glycol (OEG) based 
monomer in amphiphilic polymers offers robust aggregate formation. We also chose 
15% crosslinking as the starting point, which was accomplished by incorporating 
~15% of the pyridyldisulfide based hydrophobic monomer in the polymer.  The 
remaining 55% is used for optimizing the balance between the fluorocarbon moiety 
and the acid-degradable tetrahydropyranyl (THP) moieties. Note that the balance 
between these two moieties is likely to be the key determinant in achieving high 
fluorine content and high segmental mobility. The fluorine content is achieved by 
merely increasing the percentage of fluorocarbon moieties, while the segmental 
mobility is achieved by the decreased density of the nanogel’s interior, facilitated by 
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the acid-catalyzed removal of the THP (Figure 4.1). Three different polymers (P1-P3) 
with constant ratio of OEG:PDS (30%:15%) units and varying ratios of THP:CF3  units 
were synthesized. We systematically increased the molar ratio of fluorine content 
from 10% to 20% and to 30% in P1-P3 respectively, where the molar ratio of acid 
labile THP group decreased from 45% to 35%, and to 25%. To evaluate the 
importance of acid labile responsive group in molecular design, we included a control 
polymer (PC) into our library that lacks the acid-labile THP group. Instead, PC 
contains cyclohexyl acrylate moiety, which is structurally very close to THP but is not 
responsive to acidic pH (Chart 4.1). Another interesting control that can test the 
significance of degradable moiety is to include P6 in our library, in which there are 
no THP groups. 
 
Figure 4.1: Design and synthesis of fluorinated probe. (a) Structure of polymer 
and nanogel. (i) Nanogel formation via crosslinking of PDS groups with DTT (ii) 
Cleavage of THP group in the presence of HCl and formation of negatively 
charged moiety with NaOH addition. (b) Schematic representation of 
preparation of fluorinated nanogel with decreased interior density. 
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In addition, we were interested in exploring the properties of polymers that 
contain structurally different fluorine monomers to elucidate the effect of aromaticity 
and fluorine density. In these cases, we were interested in systematically increasing 
the number of fluorine atoms. However, we also imposed that all fluorine moieties 
should be chemically equivalent (from the side chain perspective). For this purpose, 
we designed and synthesized polymers P4-P6 (Figure 4.2). P4 contains 6 equivalent 
aromatic fluorine moieties within the monomer, while P5 and P6 contain 6 and 27 
 
Scheme 4.1: Synthesis of polymers P1, P2 and P3. 
P1-P3
 
Figure 4.2: Structure of control polymers tested in this study 
PC
R group
P4
P5
P6
(P4-P5)
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equivalent aliphatic fluorines within the monomer unit. Polymer P1, P2 and P3 with 
constant ratio of OEG:PDS (30%:15%) unit and varying ratios of THP:CF3 units have 
been synthesized via free radical polymerization technique (Scheme 4.1). We 
systematically increased the molar ratio of fluorine content from 10% to 20% and to  
 
Figure 4.3: 1H NMR spectra of polymers (P1-P3) showing the variation of THPA 
and TFEMA monomer ratios. 
CH2-CF3
CH
P2
P3
P1
P1-P3
P1 x:y:z:z’=30:15:45:10
P2  x:y:z:z’=30:15:35:20
P3 x:y:z:z’=30:15:25:30
 
Figure 4.4: GPC trace of polymer P1, P2, P3 and PC. 
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30% in P1-P3 respectively, where the molar ratio of acid labile THP group decreased 
from 45% to 35%, and to 25% (Figure 4.3). All polymers were successfully 
synthesized and characterized by NMR and GPC (Figure 4.3, Figure 4.4b and Table 
4.1). 
4.3 Nanogel Formation and Cleavage of Acid-Responsive Moiety  
Assemblies were conveniently prepared in PBS buffer (10mM, pH=7.4) and 
the hydrodynamic radii were measured by dynamic light scattering (DLS). Polymers 
formed small size assemblies with narrow distribution of P1, P2, P3 and PC having 6, 
8, 9 and 14 nm, respectively (Table 4.1 and Figure 4.5). Then, polymer assemblies 
were chemically crosslinked with the addition of dithiothreitol (DTT) to yield 
polymer nanogels (P1X, P2X, P3X and P3X). Deficient amount of DTT cleaves PDS 
group efficiently and converts it to free thiol, which then react with equal amount of 
PDS to cause inter/intra-chain crosslinkage of polymer assembly. We added 50 mol 
% of DTT against total PDS group in each polymer to obtain complete crosslinking. 
Nanogel formation is confirmed by the release of water soluble byproduct, 2-
Table 4.1: Polymer characterization via GPC. Size change of polymer 
assemblies in response to crosslinking and acid degradation. 
polymer Mn (Ð)a 
Comonomer 
composition 
(OEG:PDS:THP:CF3)b 
Size (nm)c 
Polymer 
assembly 
Polymer 
nanogel 
Acid Degraded 
nanogel 
P1   8 800 (1.77) 30:15:45:10 6 8 9 
P2 11 900 (2.50) 30:15:35:20 8 9 10 
P3 11 200 (2.35) 30:15:25:30 8 9 10 
PC 11 700 (2.57)  30:15:25:30b 13 13 13 
aMn measured by GPC. bMonomer feed ratios. cSize distribution is measure via dynamic light 
scattering. dCHA is used instead of THP. 
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pyridothione, through monitoring the characteristic absorption peak at 341nm 
(Figure 4.6). Once the stable nanogels are formed, partial degradation of hydrophobic 
interior is achieved by the addition of HCl to hydrolyze the acid responsive group. 
Next, acidic pH is neutralized back to 7.4 with the addition of base (NaOH) and final 
degraded nanogel are denoted as P1H, P2H, P3H and PCH. We showed that there is 
no drastic change in size and nanogels composition throughout the whole process. 
There is a very slight increase in size observed after acid degradation for pH-
responsive polymers, which could be due to the electrostatic repulsion of resultant 
anionic side chains at neutral pH (Table 4.1). 
 
 
Figure 4.5: Size distribution of polymer assembly, polymer nanogel and acid 
degraded polymer nanogel; (a) P1, (b) P2, (c) P3 and (c) PC. 
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4.4 19F NMR Analysis 
Spin-spin (T2) and spin-lattice (T1) relaxation times are the measure of 
molecular mobility and important parameters for 19F MRI performance. Hydrophobic 
aggregation of fluorine probe restricts the local motion of 19F nuclei and heavily 
influences these relaxation times, specially T2. Major challenge of successful 19F MRI 
probe is aggregation induced signal attenuation and loss of signal intensity in 
aqueous milieu. This phenomenon is evident in our current amphiphilic polymer 
systems as well. When polymers are dissolved in chloroform without self-assembly, 
the fluorine segments are completely flexible, which results in long T2 and much 
suppressed chemical shift anisotropy. As a result, a sharp single peak is observed in 
each polymer at around -73.25 ppm on 19F NMR spectra (Figure 4.7). T2 times of P1, 
P2, P3 and PC in chloroform were found to be 141, 153, 160 and 193 ms, respectively. 
 
Figure 4.6: (a) DTT crosslinking reaction of polymer assembly. (b-d) 
Absorption spectra of pyridothione at 341 nm for P1, P2 and P3, respectively, 
confirming the formation of polymer nanogel. 
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However, when polymers were dissolved in biologically relevant solvent (PBS 
buffer), molecular self-assembly caused a drastic decrease in relaxation times, 
especially in T2, because of its high sensitivity to changes in packing and conformation 
(Figure 4.7a). This phenomenon is evident in all polymer assemblies, but much more 
significant in polymers that contain aromatic fluorine monomers (P4) as well as in 
polymers with increasing fluorine density (P5) (Figure 4.8). 19F NMR peaks in 
aqueous solution were very weak and T2 relaxation times were too short to measure 
accurately. These results indicate that the fluorine monomers with aromatic 
structure or with higher fluorine density are not ideal for achieving higher mobility 
in these types of systems. This is understandable, as amphiphilic assemblies driven 
by aromatic units have been shown to exhibit significant increase in aggregate 
stability.48,49 This explanation is further supported with our observation with P6, 
 
Figure 4.7: 19F NMR spectra of P1, P2, P3 and PC in CDCl3 and PBS/D2O (90:10). 
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where the observed low T2 could be attributed to the highly aromatic rigid core 
associated with unused PDS groups that decreased the chain flexibility. 
 
Although the assemblies of P1-P3 in PBS/D2O (90:10, v/v) presented peak 
broadening in 19F NMR due to a decrease in T2 relaxation time, peak intensities were 
considerably higher than other polymers with a single peak between -73.11 and -
 
Figure 4.8: 19F NMR spectra of P4, P5 and P6 in CDCl3 and in PBS/D2O (90:10) 
with TFA as an internal standard. 
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73.28 ppm (Figure 4.7). Each of these polymers exhibited three different T2 values in 
PBS buffer with varying intensity, suggesting that the aggregation of polymer resulted 
in a three-component system in terms of fluorine microenvironment. The reason for 
this could be the non-uniform distribution of monomers in a statistical polymer chain. 
Difference in relative reactivity of monomers can add gradient feature into random 
copolymer structure and yield partial blockiness. As such, the segmental mobility of 
19F will differ depending on whether the nuclei are in the nanoparticle core or corona. 
On average, all three polymers exhibited three T2 relaxation times of ~ 4 ms (60%), 
~17ms (30%), and ~ 130 ms (10%) (Table 4.2). Average value of T2 for polymer 
assemblies were calculated based on the respective intensity ratios and found to be 
21, 20, and 21 ms for P1, P2, and P3, respectively. It is worth noting that the T2 of 
longest relaxing component is the highest in P3 (146 ms, 9.5%) compared to P1 (130 
ms, 9.8%) and P2 (119 ms, 11.3%), but the value is compensated by the largest 
amount of shortest relaxing component of P3 (3.8 ms, 65.5%). The opposite trend 
holds true for P1, where the average T2 becomes similar to P2 and P3 in spite of its 
 
Figure 4.9: 19F NMR relaxation times of P1, P2, P3 and PC in CDCl3 and 
PBS/D2O (90:10); (a) T2 relaxation time. (b) T1 relaxation time. 
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low value of long relaxing component that is compensated by the smaller amount of 
short relaxing component of P1 (4.3 ms, 56.7%). At last, the strongest effect on T2 due 
to association of fluorine is observed in control polymer, PC, in which the relaxation 
time is decreased from 193 ms to 5.1 ms having 94% of 3 ms component out of two. 
T1 relaxation times for all polymers decreased from ~520 ms in CDCl3 to ~ 360 ms in 
PBS/D2O (Figure 4.9). As we discussed earlier, short T1 is desired for attaining strong 
signal in MRI. Therefore, decrease in T1 relaxation time impacts the overall imaging 
positively by shortening scan time and improving signal to noise ratio.  
Table 4.2: T2 relaxation time of P1, P2, P3 and PC in PBS/D2O (90:10, v/v) 
 
Component 1 Component 2 Component 3 Avg. 
T
2 
(ms) 
T
2 
(ms) Int. % T
2 
(ms) Int. % T
2 
(ms) Int. % 
P1 4.3 56.7 16.2 32.0 119 11.3 21.2 
P2 3.8 62.3% 16.8 27.9% 130 9.8% 19.8 
P3 3.8 65.5% 18.5 25.0% 146 9.5% 21 
PC 3.0 93.9% 37.7 6.1% - - 5.1 
 
Next, we investigated the change in relaxation times upon acid degradation of 
nanogels. But prior to the acid hydrolysis, stabilization of polymer assembly through 
crosslinking is essential. Otherwise, the polymer assembly may lose its nanoparticle 
morphology due to the loss of hydrophilic - lipophilic balance after acid degradation 
of hydrophobic THP groups. We expected a slight decrease in T2 relaxation time upon 
mild crosslinking since it has been previously shown that the high degree of 
branching reduced the chain flexibility in HBPs.44  However, average T2 relaxation 
times of nanogels were slightly increased to 27, 24, and 24 ms for P1X, P2X, and P3X, 
respectively (Table 4.3). We assume that this could be ascribed to the consumption 
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of PDS groups during the crosslinking reaction. Although, the core of the nanoparticle 
is rigidified through chemical crosslinking, cleavage of hydrophobic PDS groups 
minimizes the overall hydrophobicity and increases the segmental flexibility. Similar 
trend is observed for PCX, whose average T2 is increased from 5.1 ms to 6.1 ms. Small 
changes in both T2 value and respective ratios of each component contributed to the 
final evolution of average T2.  
Table 4.3: Evolution of T2 relaxation time with the respect to crosslinking and the 
acid degradation in P1, P2, P3 and PC. 
 
Component 1 Component 2 Component 3 Avg. 
T2 (ms) T
2 
(ms) Int. % T
2 
(ms) Int. % T
2 
(ms) Int. % 
P1 4.3 56.7 16.2 32.0 119 11.3 21.2 
P1X 4.8 54.5 22.1 32.3 128 13.2 26.7 
P1H 10.4 33.7 37.8 44.5 155 21.8 52.9 
P2 3.8 62.3% 16.8 27.9% 130 9.8% 19.8 
P2X 4.2 60.3% 22.0 28.1% 134 11.6% 24.2 
P2H 4.3 54.3% 22.1 32.4% 137 13.3% 27.7 
P3 3.8 65.5% 18.5 25.0% 146 9.5% 21 
P3X 3.7 61.5% 20.6 26.7% 138 11.8% 24 
P3H 5.7 47.5% 27.5 36.5% 144 16.0% 35.8 
PC 3.0 93.9% 37.7 6.1% - - 5.1 
PCX 2.5 88.6% 14.0 9.7% 147 1.7% 6.1 
PCH 3.0 98.0% 46.0 2.0% - - 3.9 
 
Acid hydrolysis of THP was carried out at pH of 2 for 4 hours followed by the 
addition of base neutralization. The role of base addition is to bring back the pH to 7.4 
and trigger the deprotonation of acrylic acid moieties. Otherwise, protonated 
carboxylic acid groups would behave as hydrophobic side chains and then enhance 
the chain rigidity. The ratio of degradable moiety is varied from 45% to 35% and to 
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25% for P1, P2, and P3 while the ratio of fluorine is increasing from 10% to 20% and 
to 30%, respectively. Since P1 retains the highest amount of acid labile group, the 
highest level of enhancement in segmental mobility is expected. In accordance with 
our hypothesis, we have observed an increase in average T2 of more than a factor of 
two for P1 (21 ms to 53 ms), which was the greatest enhancement in comparison to 
P2 and P3 (Figure 4.10a). Overall increase in T2 is from the contribution of all three 
components. After acid degradation, the shortest relaxing component of P1 increased 
from 4.3 ms to 10.4 ms, while its relative ratio is decreased from 56.7% to 33.7% 
whereas both value and ratio of medium relaxing and long relaxing components 
increased from 16.2 (32%) ms to 37.8 ms (44.5%) and from 119 ms (11.3%) to 155 
ms (21.8%), respectively. We observed the same trend of T2 enhancement for each 
component for P2 and P3 except the extent of increase was less than P1, indicating 
that the internal flexibility is improved by the removal of THP groups. This 
phenomenon is confirmed by the studies on control polymer, PC, where the T2 was 
indeed decreased from 5.1 ms to 3.9 ms. Surprisingly, enhancement in P3 (21 ms to 
 
Figure 4.10: Evolution of T2 relaxation time with the respect to crosslinking 
and the acid degradation in P1, P2, P3 and PC. (a) T2 relaxation time. (b) T1 
relaxation time. 
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36 ms) was larger than P2 (20 ms to 28 ms) even though its ratio of THP group is 
lower than P2. 
There is no significant change in T1 observed for all polymers during the 
crosslinking and the acid treatment. All polymers before and after acid treatment 
exhibited only one T1 relaxation value within same range, meaning that the change in 
interior plasticity and conformation do not affect the spectral density of motions at 
500 MHz range (Figure 4.10b) 
4.5 19F MRI Phantom Imaging Analysis 
To test the potential application of these fluorinated polymers as CA in 19F MRI, 
we conducted phantom imaging analysis of polymers in each step. All polymers 
assemblies showed strong signal in phantom imaging at 15 mM fluorine 
concentration as well as 20 mg/mL polymer concentration using ultrashort TE pulse 
sequence (UTE) on 3T Clinical MRI (Figure 4.11a). Images were scanned in an NMR 
tube with narrow receiver coil. When we switched to bigger size receiver coil, which 
is normally used for small animal MRI, 19F signal intensity was significantly 
decreased. But, the image contrast was adequate at 20 mg/mL polymer concentration 
 
Figure 4.11: 19F MRI phantom images of P2 and P3. (a) Both polymers are in 
15 mM 19F concentration in PBS. (b) Both polymers are in 20 mg/mL 
concentration in PBS (19F concentrations are 45 mM in P2 and 67 mM in P3). 
P3P2
a) b)
P2 P3
19F Image 19F Image
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to progress the analysis. Since the highest T2 enhancement was observed in P1, 19F 
MRI imaging were conducted for P1 series and PC as a comparson. Concentration of 
fluorine moiety were kept same within P1 series (22 mM) except PC (67mM). 
However, there was no appreciable increase in signal intensity was detected, which 
could be due to the low 19F content in P1 (Figure 4.12a). Although the flexibility of 
polymer interior improved, signal intensity was not benefited from this feature as 
P1H has such small amount of 19F. In contrast, MRI signal intensity of P3 increased 
from 17.7 to 22.3 upon acid degradation, as it is shown in Figure 4.12b and c. Despite 
the same 19F concentration (67 mM), signal intensity in P3H is greater than P3, P3X 
and PC, suggesting that the MRI signal intensity of polymer nanogel was actually 
improved by reducing the density of hydrophobic interior via removal of stimuli-
responsive side chain.  
 
Figure 4.12: (a) 1H and 19F phantom MRI images of P1 series and PC. (b,c) 19F 
MRI phantom image of P3 series along with PC and the relative signal intensities. 
19F MRI1H MRI 19F MRI
P1X P1
P5 P1H
a) b) c)
P3 P-control
0
2
4
14
16
18
20
22
1
9
F
 M
R
I 
S
ig
n
a
l 
In
te
n
s
it
y
 P
 PX
 PH
P1X P1
P5 P1H
P3 P3X
P3H P5
  123 
4.6 19F MRI Animal Imaging Analysis 
To test the feasibility of fluorinated nanogels for animal imaging, intravenous 
injection of polymer nanogel to mouse and subsequent 19F MRI imaging was 
performed. In the first trial of animal imaging experiment, 0.2 mL of sterile mixture 
of fluorinated polymers in PBS buffer at 130 mM fluorine concentration was 
intravenously injected to SKH1 (hairless) mouse. The animal was scanned for 1H MRI 
and 19F MRI sequentially 30 min after the injection using TSE pulse sequence. We 
found out fluorinated nanoparticles were mostly in the blood pool during the imaging 
and the spectroscopic signal in vivo was strong (Figure 4.13). 
We continued animal imaging with our most promising polymer, P3H, which 
has shown strongest MRI signal according to phantom imaging. In the second trial, 
we decided to use a mouse model with induced inflammation to see if the polymers 
will accumulate around the inflammation area. Two mouse models (DBA/2) with 
inflammation induced by LPS in Matrigel, where the injection was performed in the 
left forepaw biceps muscle to keep this site within the field of view during MRI 
 
Figure 4.13: In vivo 1H and 19F MRI images of mixed polymer micelles (P1, P2 
and P3) in a mouse 30 min after injection. It is clear from a composite image that 
the polymer nanoparticles are in blood pool with a strong 19F MRI signal. 
1H MRI19F MRI Overlay
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imaging. The inflammation in mouse 1 shows as black on T1 and T2-weighted MRI 
image, which is due to the air bubble trapped in the gel. Normally, Matrigel looks 
bright on T2-weighted image, which is apparent in mouse two inflammation. These 
two mice were injected with 0.1 mL of sterile P3H polymer nanogel at ~650 mM 
fluorine concentration and scanned for 1H and 19F MRI after 2 hr and 72 hr time points 
(Figure 4.14). In both models, considerable amount of 19F signal detected after 2 hr, 
having strong signal from heart and carotid arteries indicating that the particles are 
abundantly in blood circulation. Signal intensity did not decrease considerably after 
72 hours, which demonstrates that these fluorinated nanogels have long circulation 
 
Figure 4.14: In vivo composite images of 1H and 19F MRI in mouse 1 and mouse 
2. Both mice have induced inflammation on forepaw biceps, seen on images as I 
(inflammation). Each mouse was injected with P3H at same concentration and 
scanned after 2 hr and 72 hr. Clear signal coming from heart (H) and carotid 
arteries (CA). 
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half-life. Also, accumulation of particles around the inflammation area was increased 
over time in each animal model.  
To show that 19F signal is associated with polymer nanogel but not with the 
animal itself, we carried out 1H and 19 MRI imaging for a mouse model without any 
injection. There was no fluorine signal detected during 19F MRI scanning from this 
animal, which indicates that there is no fluorine in animal body that is sensitive to 
MRI imaging and the positive signal we receive is exclusively attributed to the 
fluorinated polymer nanogels that is given to the animal (Figure 4.15).  
4.7 Surface Functionalization of Polymer Nanogel 
In addition to the demonstration of the potential utility as polymeric MRI 
tracer, we were interested in testing whether the same nanogels can also be used for 
targeting and as a therapeutic carrier.  Such a demonstration would suggest its future 
for theranostics.52-55 In addition to the stabilization of polymer assembly formation, 
the PDS groups also offer a convenient handle for surface functionalization. In this 
 
Figure 4.15: In vivo 1H and 19F MRI images of mouse without any polymer 
injection, eliciting that there is no 19F signal inherent to animal body. 
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study, nanogels were conveniently functionalized with small amount of folate ligands; 
folate receptor has been previously shown to be overexpressed in various cancer 
cells.56-58 In addition to cell targeting ligand, nanogels can be labeled with fluorescent 
tag molecules that can be used as a handle to monitor the cell uptake by optical 
microscopy (Figure 4.16). Thiolated versions of folic acid and fluorescein 
isothiocyanate, fluorescent marker (FITC), were sequentially attached to the surface 
of polymer nanogel by means of thiol exchange reaction with remaining PDS groups. 
Successful post-conjugation of P3 is confirmed by the absorption spectrum of 
polymer nanogel after the extensive dialysis (Figure 4.17a). To show the capability of 
guest encapsulation in nanogels, hydrophobic cyanine dye, DiI, has been incorporated 
(Figure 4.17b). 
 
Figure 4.16: (a) Representation of nanogel surface functionalization. (b) Surface 
functionalization of nanogel with FITC and FA through disulfide exchange 
reaction. 
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4.8 Cell Targeting and Cell Internalization 
Efficient cell uptake of folate decorated nanogels has been demonstrated with 
folate+ HeLa cell line. To show the capability of stable guest encapsulation of 
 
Figure 4.18: (a) UV absorption spectroscopy of DiI encapsulation and FITC 
conjugation of P3. (b,c) Flow cytometry analysis of HeLa cells incubated with 
P3 nanogels with or without FA-conjugation. 
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Figure 4.17: (a) UV absorption spectroscopy of crosslinking and surface 
modification of P3. (b) UV absorption spectroscopy of DiI encapsulation and 
FITC conjugation of P3. 
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nanogels, during the the cell uptake, DiI encapsulated P3 nanogels was used. After 2 
hr of incubation, confocal microscopy was taken (Figure 4.20 and Figure 4.20). 
 
Figure 4.19: (a) Confocal microscopy imaging of HeLa cells incubated with DiI 
encapsulated P3. DiI is in red, nucleus in blue, and cytoplasm in magenta. 
 
Figure 4.20: (a) Confocal microscopy imaging of HeLa cells incubated with DiI 
encapsulated P1-P3. DiI is in red, nucleus in blue, and cytoplasm in magenta. 
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4.9 Cell Viability with or without Chemotherapeutic Drug 
Cell labeling and tracking with 19F MRI probe has become clinically approved 
technology. It has unlimited traits if we can further advance the diagnostic feature by 
delivering treatment directly to the target site. Thanks to the hydrophobic interior of 
polymeric assemblies, hydrophobic guest molecules can be sequestered non-
covalently in aqueous environment. For this reason, we encapsulated 
chemotherapeutic drug molecule within the hydrophobic interior of nanoparticle and 
tested the in vitro cell viability. Hydrophobic chemotherapeutic agent, docetaxel 
(DOC), has been used as a model drug in this study. As it is illustrated in Figure 4.21, 
P3 with drug in it has exhibited 50% of cell killing at concentration of ~10 g/mL 
whereas there is no significant toxicity relevant to the polymer nanogel itself. 
4.10 Conclusions 
In summary, we report on a novel polymeric design that has the potential as a 
multimodal imaging platform, based on 19F MRI imaging. We show here that: (i) self-
assembly of amphiphilic polymers, driven by the hydrocarbon and fluorocarbon 
 
Figure 4.21: MTT assay of HeLa cells incubated with empty and docetaxel 
encapsulated P1, P2 and P3. 
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species can be used to embed 19F moieties within a water-soluble polymeric 
nanoparticle; (ii) the NMR and relaxation time loss associated with the reduced 
segmental mobilities in these aggregates can be mitigated by preserving the 
morphology of the assembly through crosslinking, followed by release of 
hydrophobic moieties to increase segmental mobilities within the nanogel interior; 
(iii) MR imaging of the nanogels indicates that a balance between the critical number 
of fluorine moieties required for MR signals from the polymer and the degree of 
enhancement in segmental mobility is needed; (iv) the ability to decorate these 
nanogels with fluorophores and utilize their interior to encapsulate drug molecules 
within their interiors, combined with the inherent biocompatibility of the nanogels, 
indicate that these nanogels hold promise in multimodal imaging and theranostics 
applications. Indeed, extending this work in theranostics applications is part our 
laboratory’s foci. 
4.11 Experimental Details 
4.11.1 Synthesis and Characterization 
All chemicals and reagents were purchased from commercial sources and 
were used as received, unless otherwise mentioned. Polyethylene glycol monomethyl 
ether acrylate (PEGA; 480), 2,2,2-trifluoroethyl methacrylate (TFEMA), DL-
dithiothreitol (DTT), folic acid, fluorescein isothiocyanate isomer I, 1,1′-Dioctadecyl-
3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI) were obtained from Sigma-
Aldrich. 2,2-azobis(2-methylpropionitrile) (AIBN) was purchased from Sigma-
Aldrich and purified by recrystallization in cold methanol for three times. Cyclohexyl 
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acrylate (CHA) and docetaxel were purchased from TCI America. Pyridyl disulfide 
ethyl acrylate (PDSA) and compound 2 were synthesized according to previously 
reported procedures.60,61 Thiolated version of folic acid (FA-SH) and fluorescein 
isothiocyanate (FITC-SH) were prepared using to the previously reported 
procedures.47 
4.11.1.1 Synthesis of P1 
PEGA (0.398 g, 0.83 mmol), PDSA (0.1 g, 0.415 mmol), THPA (0.194 g, 1.245 
mmol) and AIBN (4.5 mg, 0.0277 mmol) were weighed into small round bottom flask 
and purged with argon. Reaction mixture was dissolved in 0.75 mL of previously 
degassed dry THF. TFEMA (40 L, 0.277 mmol) was separately degassed (15 min) 
and added with syringe. After that the reaction mixture was sealed and transferred to 
preheated oil bath at 65 oC and stirred for 20 hours. Polymerization was stopped by 
cooling down the flask in cold water. Product was purified with extensive dialysis 
against DCM:MeOH (3:1, v/v) for three days. Yield: 96%. GPC (THF) Mn:8800 Da. 
Ð:1.77. 1H NMR (500 MHz, CDCl3): 8.42, 7.64, 7.07, 5.90, 4.42-4.13, 3.80, 3.60-3.34, 
2.98, 2.31-1.01. 13C NMR (125 MHz, CDCl3): 174.5, 159.6, 149.2, 138.0, 124.6, 122.1, 
120.5, 101.1, 100.2, 98.6, 94.9, 72.1, 70.7, 69.1, 63.9, 63.5, 63.1, 60.9, 59.1, 53.5, 45.5, 
41.2, 37.2, 32.0, 31.0, 30.8, 25.4, 20.3, 19.9, 19.5, 19.1. 
4.11.1.2 Synthesis of P2 
PEGA (0.398 g, 0.83 mmol), PDSA (0.1 g, 0.415 mmol), THPA (0.152 g, 0.968 
mmol) and AIBN (4.5 mg, 0.0277 mmol) were weighed into small round bottom flask 
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and purged with argon. Reaction mixture was dissolved in 0.75 mL of previously 
degassed dry THF. TFEMA (79 L, 0.553 mmol) was separately degassed (15 min) 
and added with syringe. After that the reaction mixture was sealed and transferred to 
preheated oil bath at 65 oC and stirred for 20 hours. Polymerization was stopped by 
cooling down the flask in cold water. Product was purified with extensive dialysis 
against DCM:MeOH (3:1, v/v) for three days. Yield: 97%. GPC (THF) Mn:11900 Da. 
Ð:2.50. 1H NMR (500 MHz, CDCl3): 8.44, 7.65, 7.09, 5.91, 4.42-4.14, 3.82, 3.63-3.35, 
2.99, 2.32-1.01. 13C NMR (125 MHz, CDCl3):174.9, 159.6, 149.8, 144.3, 137.7, 124.3, 
122.4, 121.1, 120.0, 100.9, 99.9, 98.7, 94.6, 93.1, 72.1, 70.7, 68.8, 65.9, 64.0, 62.1, 60.9, 
59.3, 55.2, 45.9, 41.5, 37.2, 32.0, 30.8, 25.8, 22.9, 20.5, 19.5, 18.3, 8.8. 
4.11.1.3 Synthesis of P3 
PEGA (0.398 g, 0.83 mmol), PDSA (0.1 g, 0.415 mmol), THPA (0.108 g, 0.692 
mmol) and AIBN (4.5 mg, 0.0277 mmol) were weighed into small round bottom flask 
and purged with argon. Reaction mixture was dissolved in 0.75 mL of previously 
degassed dry THF. TFEMA (118 L, 0.830 mmol) was separately degassed (15 min) 
and added with syringe. After that the reaction mixture was sealed and transferred to 
preheated oil bath at 65 oC and stirred for 20 hours. Polymerization was stopped by 
cooling down the flask in cold water. Product was purified with extensive dialysis 
against DCM:MeOH (3:1, v/v) for three days. Yield: 98%. GPC (THF) Mn:11200 Da. 
Ð:2.35. 1H NMR (500 MHz, CDCl3): 8.43, 7.64, 7.08, 5.90, 4.41-4.13, 3.81, 3.61-3.34, 
2.98, 2.30-0.92. 13C NMR (125 MHz, CDCl3): 175.0, 159.5, 149.8, 144.3, 137.6, 124.5, 
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122.1, 121.2, 120.1, 100.8, 98.6, 94.5, 72.0, 70.7, 68.9, 65.9, 64.0, 62.6, 61.0, 59.1, 45.4, 
44.8, 41.2, 39.3, 37.3, 32.1, 31.1, 30.7, 25.3, 22.9, 20.3, 19.7, 18.2. 
4.11.1.4 Synthesis of PC 
PEGA (0.398 g, 0.83 mmol), PDSA (0.1 g, 0.415 mmol), CHA (0.128 g, 0.692 
mmol) and AIBN (4.5 mg, 0.0277 mmol) were weighed into small round bottom flask 
and purged with argon. Reaction mixture was dissolved in 0.75 mL of previously 
degassed dry THF. TFEMA (118 L, 0.830 mmol) was separately degassed (15 min) 
and added with syringe. After that the reaction mixture was sealed and transferred to 
preheated oil bath at 65 oC and stirred for 20 hours. Polymerization was stopped by 
cooling down the flask in cold water. Product was purified with extensive dialysis 
against DCM:MeOH (3:1, v/v) for three days. Yield: 83%. GPC (THF) Mn:11700 Da. 
Ð:2.57. 1H NMR (500 MHz, CDCl3): 8.45, 7.65, 7.09, 4.69, 4.42-4.15, 3.76, 3.63-3.36, 
3.00, 2.26-0.94. 13C NMR (100 MHz, CDCl3):174.1, 159.6, 149.7, 137.6, 124.5, 121.7, 
121.2, 120.0, 73.1, 72.0, 70.5, 69.0, 63.6, 62.5, 61.0, 59.1, 45.6, 41.2, 37.1, 31.6, 25.4, 
23.8, 20.0, 18.0. 
4.11.1.5 Synthesis of Compound 1 
 
 
To a solution of 3,5-bis(trifluoromethyl)benzoic acid (3.0 g, 11.62 mmol) in 
dry dichloromethane was added 2-Hydroxyethyl acrylate (1.04 g, 8.94 mmol) and 
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cooled to 0 oC in ice bath. To this mixture N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (2.23 g, 11.62 mmol) and 4-(dimethylamino) 
pyridine (0.13 g, 1.07 mmol) were added. The reaction mixture was stirred for 3 
hours at room temperature. Distilled water was added to the reaction mixture and 
extracted three times with dichloromethane. Combined organic layers were dried 
over anhydrous Na2SO4 and evaporated to dryness.  The product was purified by silica 
gel column chromatography using ethyl acetate/hexane as eluent to yield 1.23 g 
(39%) of pure compound 1. 1H NMR (400 MHz, CDCl3) δ 8.48 (s, 2H), 8.07 (s, 1H), 6.45 
(d, J = 17.3 Hz, 1H), 6.16 (dd, J = 17.3, 10.4 Hz, 1H), 5.88 (d, J = 10.4 Hz, 1H), 4.64 (d, J 
= 4.8 Hz, 2H), 4.54 (d, J = 4.8 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 166.1, 163.9, 132.4 
(q, JC-F = 34 Hz), 132.2, 131.9, 130.1, 127.8, 126.8-126.7 (m), 124.3, 121.6, 119.0, 64.0, 
62.0. 
4.11.1.6 Synthesis of P4 
Compound 1 (0.309 g, 0.868 mmol), PEGA (0.5 g, 1.042 mmol), PDSA (0.139 g, 
0.578 mmol), CHA (0.189 g, 1.215 mmol), Cyanomethyl dodecyl trithiocarbonate 
(27.6 mg, 0.0868 mmol) and AIBN (3.0 mg, 0.0173 mmol) were weighed into small 
schlenk flask and dissolved in 1 mL of dry toluene. Reaction mixture is degassed 
through three cycles of freeze-pump-thaw, transferred to preheated oil bath at 80 oC 
and stirred for 20 hours. Polymerization was stopped by cooling down the flask in 
cold water. Product (P4) was purified with extensive dialysis against DCM:MeOH 
(3:1, v/v) for three days. Yield: 79%. GPC (THF) Mn:13100 Da. Ð:1.25. 1H NMR (400 
MHz, CDCl3): 8.47, 8.04, 7.68, 7.12, 6.03, 4.57, 4.40-4.14, 3.76, 3.63-3.36, 3.02, 2.41, 
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1.84-1.69, 1.24, 0.86. 13C NMR (100 MHz, CDCl3):174.6, 163.7, 158.6, 149.5, 137.9, 
131.9, 130.0, 126.6, 124.1, 121.4, 120.0, 118.8, 99.0, 98.4, 94.5, 71.8, 70.4, 68.9, 63.5, 
62.2, 59.1, 41.1, 36.8, 34.8, 32.0, 29.8, 29.4, 25.4, 22.9, 20.3, 14.3. 
4.11.1.7 Synthesis of Compound 3 
 
 
 
Compound 2 was prepared according to previously reported procedure.61 To 
a solution of Compound 2 (2.36 g, 2.78 mmol) in dry dichloromethane was added 
triethylamine (0.46 mL, 3.33 mmol) and cooled to 0 oC in ice bath. To this mixture 
acryloyl chloride (.25 mL, 3.06 mmol was added. The reaction mixture was stirred for 
4 hours at room temperature. Distilled water was added to the reaction mixture and 
extracted three times with dichloromethane. Combined organic layers were dried 
over anhydrous Na2SO4 and evaporated to dryness.  The product was purified by silica 
gel column chromatography using ethyl acetate/hexane as eluent to yield 0.92 g 
(37%) of pure Compound 3. 1H NMR (400 MHz, CDCl3) δ 6.39 (dd, J = 17.3, 1.5 Hz, 
1H), 6.10 (dd, J = 17.3, 10.4 Hz, 1H), 5.82 (dd, J = 10.4, 1.5 Hz, 1H), 4.20 (t, J = 6.4 Hz, 
2H), 4.04 (s, 6H), 3.48 (t, J = 6.3 Hz, 2H), 3.38 (s, 2H), 1.92 (p, J = 6.3 Hz, 2H). 13C NMR 
(100 MHz, CDCl3) δ 166.5, 131.1, 128.3, 124.5 (q, JC-F = 292.5 Hz), 79.4 (m), 67.8, 65.4, 
64.8, 61.4, 46.4, 28.7.  
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4.11.1.8 Synthesis of P5 
Compound 3 (25 mg, 0.0277 mmol), PEGA (0.2 g, 0.416 mmol), PDSA (67 mg, 
0.277 mmol), THPA (0.104 g, 0.666 mmol) and AIBN (2.3 mg, 0.0138 mmol) were 
weighed into small round bottom flask and purged with argon. Reaction mixture was 
dissolved in 0.4 mL of previously degassed dry THF. After that the reaction mixture 
was sealed and transferred to preheated oil bath at 65 oC and stirred for 20 hours. 
Polymerization was stopped by cooling down the flask in cold water. Product (P5) 
was purified with extensive dialysis against DCM:MeOH (3:1, v/v) for three days. 
Yield: 97%. GPC (THF) Mn:9800 Da. Ð:1.96. 1H NMR (500 MHz, CDCl3): 8.41, 7.64, 
7.06, 5.88, 4.25-3.98, 3.77, 3.59-3.50, 3.32, 2.98, 2.31-1.59, 1.120. 13C NMR (100 MHz, 
CDCl3):174.3, 159.3, 149.5, 144.0, 137.6, 121.4, 121.1, 119.6, 118.6, 100.9, 98.8, 
94.7, 94.3, 92.6, 71.8, 70.44, 68.9, 65.8, 63.8, 63.5, 62.3, 59.1, 41.1, 36.8, 35.1, 31.8, 
31.0, 29.0, 25.2, 24.8, 22.6, 20.3, 19.5, 18.3.
4.11.1.9 Synthesis of P6 
PEGA (0.2 g, 0.415 mmol), PDSA (0.2 g, 0.830 mmol), TFEMA (20 L, 0.138 mmol), 
Cyanomethyl dodecyl trithiocarbonate (5.8 mg, 0.0184 mmol) and AIBN (0.6 mg, 0.0037 
mmol) were weighed into small schlenk flask and dissolved in 0.4 mL of dry THF. 
Reaction mixture is degassed through three cycles of freeze-pump-thaw, transferred to 
preheated oil bath at 65 oC and stirred for 24 hours. Polymerization was stopped by 
cooling down the flask in cold water. Product (P6) was purified with extensive dialysis 
against DCM:MeOH (3:1, v/v) for three days. Yield: 68%. GPC (THF) Mn:12600 Da. 
Ð:1.45. 1H NMR (400 MHz, CDCl3): 8.40, 7.63, 7.05, 4.42-4.11, 3.60-3.43, 3.34, 2.97, 
2.32-1.51, 1.22. 
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4.11.2 NMR Analysis  
4.11.2.1 1H NMR Spectra 
1H NMR spectra were recorded on 400 MHz and 500 MHz Bruker NMR 
spectrometer using the residual proton resonance of the solvent as the internal 
standard. Chemical shifts are reported in parts per million (ppm). 
 
Figure 4.22: 1H NMR spectrum of p(PEGA-co-PDSA-co-THPA-co-TFEMA), P1. 
 
Figure 4.23: 13C NMR spectrum of p(PEGA-co-PDSA-co-THPA-co-TFEMA), P1. 
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Figure 4.24: 1H NMR spectrum of p(PEGA-co-PDSA-co-THPA-co-TFEMA), P2. 
 
 
Figure 4.25: 13C NMR spectrum of p(PEGA-co-PDSA-co-THPA-co-TFEMA), P2. 
 
a
bc
d
g
h fe
i
j
k
l
m n
a
c,d
b i
g
fh e
k j
l
n
o
o
g’
g’
m
n mnm
  139 
 
 
Figure 4.26: 1H NMR spectrum of p(PEGA-co-PDSA-co-THPA-co-TFEMA), P3. 
 
 
 
Figure 4.27: 13C NMR spectrum of p(PEGA-co-PDSA-co-THPA-co-TFEMA), P3. 
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Figure 4.28: 1H NMR spectrum of p(PEGA-co-PDSA-co-CHA-co-TFEMA), PC. 
 
 
 
Figure 4.29: 13C NMR spectrum of p(PEGA-co-PDSA-co-CHA-co-TFEMA), PC. 
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Figure 4.30: 1H NMR spectrum of compound 1. 
 
Figure 4.31: 13C NMR spectrum of compound 1. 
 
 
Figure 4.32: 1H NMR spectrum of p(PEGA-co-PDSA-co-THPA-co-(CF3)2A), P4. 
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Figure 4.33: 13C NMR spectrum of p(PEGA-co-PDSA-co-THPA-co-(CF3)2A), P4. 
 
 
 
 
Figure 4.34: 1H NMR spectrum of compound 3. 
 
 
 
 
Figure 4.35: 13C NMR spectrum of compound 3. 
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Figure 4.36: 1H NMR spectrum of p(PEGA-co-PDSA-co-THPA-co-(CF3)9A), P5. 
 
 
Figure 4.37: 13C NMR spectrum of p(PEGA-co-PDSA-co-THPA-co-(CF3)9A), P5. 
 
 
 
Figure 4.38: 1H NMR spectrum of p(PEGA-co-PDSA-co-co-TFEMA), P6. 
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4.11.2.2 19F NMR Spectra 
19F NMR spectra of polymers in organic solvent (CDCl3) and PBS/D2O (90/10, 
v/v) were acquired using Bruker 500 MHz NMR spectrometer. All polymers samples 
in PBS buffer were originally prepared in 20 mg/mL concentration and diluted to 17.8 
mg/mL with 10% D2O. NMR measurements are performed with following 
parameters: 90oC pulse width 12.5 s, and 32 scans. 
4.11.2.3 19F Spin-Lattice Relaxation Time (T1) 
T1 relaxation time of all polymers in CDCl3 and PBS/D2O (90/10, v/v) were 
measured by using standard inversion-recovery pulse sequence in Bruker 500 MHz 
NMR spectrometer. All polymer samples in PBS buffer were originally prepared in 20 
mg/mL concentration and diluted to 17.8 mg/mL with 10% D2O prior to 
measurement. 19F NMR acquisitions are performed with recovery times ranging from 
1 ms to 5 s, 90oC pulse width 12.5 s, with 16 scans. Only peak intensities for major 
peak at around -72.23 to -72.29 were used for exponential functions for the 
estimation of T1. 
4.11.2.4 19F Spin-Spin Relaxation Time (T2) 
T2 relaxation times were measured using Carr-Purcell-Meilboom-Gill (CPMG) 
pulse sequence in Bruker 500 MHz NMR spectrometer. T2 of all polymer samples both 
in CDCl3 and PBS/D2O (90/10, v/v) were acquired. For each measurement, 16 data 
points were recorded with echo times ranging from 3 to 240 ms, which were then 
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analyzed by Dynamic Center Software to estimate relative relaxation times. 19F NMR 
acquisitions were performed with 90oC pulse width 12.5 s with 16 scans. 
4.11.2.5 1H and 19F MRI Phantom Imaging 
All 1H and 19F MRI phantom experiments were performed in a 3T (128 MHz 
for 1H) Achieva whole-body MRI scanner (Philips Medical Systems, Best, 
Netherlands) by using a custom-made solenoid (either 5mm or 35mm diameter) T/R 
coil and modular 19F Gateway Interface (Clinical MR Solutions, LLC Brookfield, WI). 
Either standard 5mm NMR spectroscopy tubes or 0.2 mL polypropylene PCR tubes 
were used for phantom imaging. A 3D ultrashort echo time (UTE) pulse sequence was 
used to acquire 19F MR images to maximize signal from 19F, which has a very short T2, 
and thus rapidly decaying MR signal. The 19F MR images of polymer solutions were 
acquired by using UTE (TR/TE=600/0.13 ms; FA= 65°), 6 slices; voxel size=1x1x4 
mm, field of view (FOV) of 24 mm × 24 mm. Raw images were imported and processed 
using ImageJ. Signal-to-noise ratios were calculated by normalizing the region-of-
interest mean intensity values by standard deviation of signal noise. 
4.11.2.6 1H and 19F MRI Animal Imaging 
All 1H and 19F animal experiments were performed using same custom-made 
35mm diameter solenoid T/R coil at 3.0 T. The coil was first tuned to the proton 
resonant frequency to acquire 1H images and then re-tuned to 19F resonant frequency 
to acquire 19F images. A turbo spin echo (TSE) pulse sequence was used for both 1H 
and 19F imaging. The 1H imaging parameters for T1-weighted imaging were: 6 slices 
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with slice thickness of 4 mm; field of view (FOV) = 24 mm × 30.6 mm × 50 mm with; 
TSE factor=8; TR/TE = 600/13 ms; Same geometric parameters were used for T2-
weighted 1H imaging, other imaging parameters were: TSE factor=8; TR/TE = 
3000/70 ms; Subsequently, the coil was re-tuned to 19F resonant frequency and 1H 
images were used to plan the 19F MR imaging plane. Feasibility 19F MR images were 
acquired by using TSE pulse sequence with following parameters: TSE factor=8; 
TR/TE = 1000/4.4 ms; flip angle (FA) = 90°; NSA = 39; same geometric parameters as 
1H imaging was used for 19F imaging. 
4.11.3 Dye Encapsulation 
To a vial containing 2 mL of 20mg/mL polymer solution in PBS buffer (10mM) 
added 40 µL of 10 mg/mL DiI (1% wt feed) in acetone, followed by evaporation of 
acetone by leaving the vial uncapped for 6 hours while stirring at room temperature. 
After 6 hours, the volume of polymer solution is reconstituted back to original 2 ml 
with the addition of PBS buffer. Non-encapsulated excess DiI has been removed by 
0.22 M pore size syringe filter. 
4.11.4 Drug Encapsulation 
To a vial containing 1 mL of 20mg/mL polymer solution in PBS buffer (10mM) 
added 60 µL of 66.7 mg/mL docetaxel (20% wt feed) in acetone, followed by 
evaporation of acetone by leaving the vial uncapped for 10 hours while stirring at 
room temperature. After 10 hours, the volume of polymer solution is reconstituted 
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back to original 1 ml with the addition of PBS buffer. Non-encapsulated excess 
docetaxel has been removed by 0.22 M pore size syringe filter. 
4.11.5 Crosslinking and Nanogel Preparation 
To a vial containing 2 mL of 20mg/mL polymer solution that had previously 
encapsulated hydrophobic dye molecule (DiI) added 20 µL of 45.3 mg/mL DTT 
solution. Crosslinking reaction was monitored with the UV absorption spectrometer 
by following the absorption maximum of byproduct, 2-pyridothione, at 343 nm. 
Crosslink density was calculated by using the molar extinction coefficient of 
byproduct (8.08*103 M-1cm-1 at 343 nm). 
4.11.6 Surface Modification of Nanogel with FITC-SH 
0.4 mg (1% wt. feed) of FITC-SH was dissolved in minimum amount of DMSO 
(50 µL) and added to the 2 mL of previously crosslinked nanogel solution (20 
mg/mL). After stirring for 2h in ambient condition, excess FITC-SH, DMSO and 2-
pyridothione were removed by dialysis against PBS buffer. 
4.11.7 Surface Modification of Nanogel with FITC-SH and FA-SH 
0.4 mg (1% wt. feed) of FITC-SH was dissolved in minimum amount of DMSO 
(50 µL) and added to the 2 mL of previously crosslinked nanogel solution (20 
mg/mL). After stirring for 1h, 0.4 mg (1% wt. feed) of FA-SH in 50 µL DMSO was added 
to the reaction mixture and stirred for another 1h. Finally, unreacted FITC-SH, FA-SH, 
DMSO and 2-pyridothione were removed by dialysis against PBS buffer. 
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4.11.8 Cell Study 
4.11.8.1 Cell culture 
HeLa (human cervical adenocarcinoma) were obtained from the American 
Type Culture Collection  (ATCC ID: CCL-2). Cells were cultured in Dulbecco’s Modified 
Eagle’s medium/F12 (DMEM/12) supplemented with 2 mM L-glutamine, 10 µg/mL 
streptomycin, 100 U/mL penicillin and 10% (v/v) fetal bovine serum (FBS) at 37 °C 
in a humid atmosphere of 10% CO2. When HeLa cells were grown to 90% confluency, 
cells were trypsinized for 5 mins in PBS and passaged 1:10 into a new tissue culture 
plate. Maximum number of passage was limited to 10 for HeLa cells. DMEM/F12 and 
supplements were obtained from ThermoFisher.  
4.11.8.2 MTT assay 
For cell viability assay, HeLa cells were trypsinized and counted. Cells were 
seeded on flat bottom 96-well tissue culture plates at a density of 7,000 cells/well and 
rested for 24 hours at 37 °C in 10% CO2. After overnight incubation, the culture 
medium was removed and cells were treated with empty or docetaxel loaded nanogel 
samples at different concentrations in complete medium for 24 hours. After 
treatments, cells were washed and fresh medium was added. Cells were incubated 
with the fresh medium for further 24 hours. Next day, medium was replaced with 3-
(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium solution (MTT) (prepared as 1 
mg/ml in medium) and cells were incubated for 3-4 hours at 37 °C to allow the 
formation of the MTT formazan. 96-well plate was spinned for 5 minutes to let the 
formazan settle at the bottom of the plate. MTT medium was discarded and formazan 
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was dissolved in 100 µL of DMSO. Purple color formation was observed and recorded 
using a plate reader at 540nm. 
4.11.8.3 Confocal Microscopy 
Confocal experiment was performed with Nikon A1 Spectral Detector Confocal 
(IALS, UMASS, Amherst). HeLa cells were cultured in MatTek glass bottom dishes 
until they reached the 70% confluency. DiI loaded NG samples were diluted to 0.25 
mg/mL in complete medium and incubated with cells for 2 hours at at 37 °C in 10% 
CO2. Later, cells were washed with cold PBS at least three times and samples were 
fixed with 3% paraformaldehyde. Nucleus were stained with NucBlue (Thermofisher) 
and plasma membrane were stained with CellMask Deep Red (Thermofisher). The 
Images were analyzed using NIS-Elements Software. 
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CHAPTER 5 
 SUMMARY AND FUTURE DIRECTIONS 
5.1 Summary 
Amphiphilic supramolecular assemblies have been of great interest due to 
their potential utility in a variety of applications such as drug delivery, bio-sensing 
and catalysis. This dissertation is focused on elucidating the importance of 
hydrophobic functional groups that characterize the interior rigidity and flexibility of 
micelle like supramolecular assemblies. Variety of amphiphilic dendrimers and 
polymers that carry stimuli-responsive feature have been designed, synthesized and 
tested. Based on the physical properties of assembly dictated by the interior density, 
we have demonstrated the potential applications of these nanomaterials in drug 
delivery and diagnostics.  
In Chapter 2, effect of aromatic interaction on dynamic equilibrium of unimer-
aggregate in temperature-sensitive facially amphiphilic dendron was studied. Self-
assembling dendrimers that exhibit well characterized molecular structure with 
higher thermodynamic stability allowed the highly systematic structure-property 
relationship analysis. We showed that the dynamic exchange of supramolecular 
assemblies was dramatically decreased by the incorporation of aromatic 
functionality and become less sensitive to temperature changes. Moreover, stabilizing 
effect of p-p interaction in aromatic assemblies resulted in enhanced guest 
encapsulation stability. This is the first systematic demonstration presenting the role 
of aromatic interaction in dynamic exchange of supramolecular assemblies, which 
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highlighted the subtle structural change at molecular level can control the dynamic 
behavior of nanoscale materials at macroscopic level. 
In Chapter 3, the knowledge we have gained from Chapter 2 was exploited to 
develop versatile drug delivery system that exhibits enhanced drug encapsulation 
and drug retention, which are the major limitations in the field of polymer 
nanomedicine. A series of amphiphilic polymers that consist of varying aromatic 
functional groups have been designed and prepared. Each polymer was formulated 
into stable nanoassemblies and tested with multiple chemotherapeutic and 
immunosuppressant drug molecules. We found that the increase in the rigidity of 
polymer nanoparticle via aromatic interaction indeed improved the drug 
encapsulation efficiency and loading capacity. Potential application of these drug 
carriers as an anticancer agent was demonstrated by the in vitro cell viability assay 
of cervical cancer cells. 
We have demonstrated the strategy to increase the rigidity of amphiphilic 
assemblies by incorporating aromatic functionality followed by the implication of 
these rigid particles in cancer nanomedicine. In Chapter 4, we presented a strategy to 
decrease the interior density of amphiphilic assemblies and explored the effect of 
interior flexibility on the mobility of embedded hydrophobic functional groups. In 
particular, we have designed and synthesized stimuli-responsive amphiphilic 
polymer that contains 19F nuclei as a magnetic probe and studied the change of 
mobility in terms on increasing flexibility by using NMR and MRI. Our approach to 
generate interior flexibility in polymeric assemblies was based on preserving the 
morphology of assembly via chemical crosslinking first and then degrading and 
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removing the cleavable portion from the interior of crosslinked nanogel. The 
feasibility of this approach has been confirmed by the increase in segmental mobility 
of fluorine atom and applied to 19F MRI-guided drug delivery. 
5.2 Future Direction of Nanogel-based Drug Delivery 
5.2.1 In Vitro Stability and Drug Release Study 
In Chapter 3, we have demonstrated the drug encapsulation properties and 
the in vitro cell viability of nanogels. However, in vitro encapsulation stability as well 
as the drug release profile needs to be tested. Encapsulation stability of drug-loaded 
nanogels will be analyzed by incubating the nanogels with cell culture media for 
extended period. Crosslinked nanogels are sensitive to reducing environment as their 
inner network is comprised of disulfide bond. Therefore, controlled release study of 
drug-loaded nanogel will be carried out in the presence of glutathione in biologically 
relevant condition. 
5.2.2 Targeted Delivery of Nanogels 
We have observed considerable amount of cell killing effect by using drug-
loaded nanogels. We are interested in studying whether cell killing efficiency of these 
nanogels could be improved with specific targeting ligands. Folic acid (FA) is a well 
know ligand for the folate receptor, which are prevalent on the surface of many cancer 
cells. In order to functionalize the surface of nanogel with FA-ligand, we synthesized 
thiolated version of folic acid using solid phase synthesis, which will react with free 
PDS groups via thiol-exchange reaction (Scheme 5.1).1 
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Scheme 5.1: Synthesis of thiolated folic acid using solid phase synthesis. 
5.2.3 Synergistic Effect of Combination Therapy 
We have demonstrated the efficient loading of both of paclitaxel and 
rapamycin into aromatic nanogels. Cell viability assay revealed that the PTX-nanogels 
were more efficient than RAP-nanogels. There are recent reports stating the 
synergistic cell killing effect towards breast cancer cell lines when RAP is delivered in 
combination with PTX.2,3 Therefore, we are interested in investigating codelivery of 
both drugs using our nanogel system. 
5.3 Future Direction of 19F MRI based Diagnostic 
5.3.1 Improving Segmental Mobility of 19F with Acrylate Monomer 
In all our multi-functionalized random copolymer design, we have utilized 
methacrylate version of fluorine monomer whilst others are acrylate based 
monomers. This resulted formation of partially gradient copolymer because of the 
difference in reactivity of monomers and thus led to variable conformations of 
fluorine in polymer assembly. By using acrylate based fluorine monomer, we may be 
able to improve the variability of fluorine environment and relevant T2 relaxation 
time (Scheme 5.2).4 
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Scheme 5.2: Synthesis of multi-functional fluorinated random copolymer. 
5.3.2 Light-Responsive 19F MRI Probe Design 
We have developed the pH-responsive 19F MRI probe that shows signal 
enhancement upon pH decrease. Interior flexibility of the nanaoassembly provides 
certain segmental mobility to 19F nuclei and therefore there is clear MRI signal 
intensity in the beginning. Diagnostic capability of imaging probe is high when there 
is “on-off” signal in response to environmental change.  
 
Scheme 5.3: Synthesis of light-responsive polymer. 
Therefore, we envisaged that incorporation of light-responsive aromatic 
functional group into the polymer design can endow rigidity to original assembly and 
decrease mobility of 19F, which will turn off the MRI signal. Upon light exposure to 
crosslinked nanogel, cleavage of aromatic functional group is expected to increase the 
interior flexibility as well as the segmental mobility of fluorine. 
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Scheme 5.4: Preparation of polymer nanogel and light-responsive degradation. 
Light-responsive polymer containing o-nitrobenzyl ester functional group 
were successfully synthesized and formulated into nanogel (Scheme 5.3 and Scheme 
5.4). This polymer formed stable aggregate of 21 nm in size. As we expected, mobility 
of 19F was quite low with T2 relaxation time of 7 ms. This value went up to 10 ms after 
crosslinking, which is very mild change (Figure 5.1). However, after UV-exposure, we 
did not observe any increase in T2 event though the cleavage of light-responsive 
group is prominent in UV-absorption spectrum. In future, ratio of aromatic functional 
group should be decreased well below 50% and optimized for the intended purpose 
as the reason for this low segmental mobility of fluorine could be due to too much 
aromatic groups. 
 
Figure 5.1: UV absorbance spectrum and T2 relaxation time of light-responsive 
polymer micelle, nanogel and light-degraded nanogel. 
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5.3.3 Effect of Local Density of 19F on Segmental Mobility 
Main limitation of 19F MRI is the low sensitivity. Concentration of 19F needs to 
be in mM range during the imaging. Therefore, it is important to increase the local 
concentration of fluorine in the tracer molecule. For this purpose, we designed an 
amphiphilic polymer that contains large number of fluorine attributed to its high 
fluorine content monomer. We are interested in studying the effect of local fluorine 
density on the segmental mobility using following polymer design (Scheme 5.5). 
 
 
Scheme 5.5: Synthesis of polymer with high local density of fluorine. 
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5.4 Summary 
In this final chapter, a brief summary for the previous chapters has been 
presented, highlighting the key findings and the implications of nanomaterials 
described in this dissertation. As a complement to Chapter 3 and Chapter 4, general 
ideas and relevant experiments have been provided. We designed and synthesized 
several new amphiphilic polymers as 19F MRI probe and proposed to test their 
properties in comparison to our original design. 
We believe that the fundamental understanding gained from these research 
works will pave the way for designing ideal supramolecular assemblies for 
therapeutic delivery and diagnostics applications.  
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